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Abstract 
Roquin is a recently identified autoimmune regulator. Mice with a loss of function 
mutation in Roquin have dysregulated Inducible Co-Stimulator (ICOS) expression on T 
cells and develop lupus and autoimmune diabetes. Roquin's localization to stress 
granules and a CCCH zinc finger domain predicted to bind RNA suggest a role in 
post-transcriptional regulation of gene expression. Here, we investigate the molecular 
mechanisms by which Roquin suppresses ICOS expression. We have developed an 
experimental system that can accurately quantify the suppressive effect of Roquin on 
ICOS. Using this system, we have found the 3' untranslated region (3'UTR) of Icos 
contains cw-acting element(s) that mediates Roquin's suppression. Fine mapping the 
3'UTR has led to the identification of a small regulatory region responsible for Icos 
mRNA degradation. Software-based motif prediction within this small region has shed 
light into the molecular mechanisms by which Roquin exerts this regulation. We are 
also investigating the presence of similar c/s-acting elements within the mRNAs of 
Roquin's potential targets other than ICOS, such as TNF alpha. 
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General introduction 
1.1 B cell differentiation during immune responses 
B cells secrete antibody that plays multiple protective roles in the face of infection. 
Antibodies neutralize viruses and toxins, opsonise extracellular bacteria, activate 
complement , and activate other cells including natural killer cells. B cell activation by 
protein antigens requires both binding of the antigen by B cell surface Ig: the B-cell 
receptor and interaction of the B cell with a primed antigen-specific helper T cell. This 
first cognate T: B cell interaction usually occurs in the T zones of secondary lymphoid 
tissues. After receiving T cell help, B cells differentiate along one of two pathways: 
(1) In the extrafollicular pathway B cells give rise to short lived unmutated plasma cells. 
(2) In the follicular pathway, B cells enter follicles and give rise to germinal centres 
(GCs) 
1.1.1 The Germinal center is a specialized microenvironment 
T-dependent humoral immune responses are characterized by the development of GCs 
in B cell follicles of the secondary lymphoid organs. Within these structures, B cells 
undergo somatic hypermutation targeted at the Immunoglobulin (Ig) variable (V) region 
genes. This mutations change the affinity of the B cell. While the goal is the production 
of high affinity mutants, loss of antigen reactivity and acquisition of self-reactive 
specificities can also occur (Diamond and Scharff, 1984; Winkler et al., 1992). 
Importantly, the germinal center environment filters the repertoire of differentiating B 
cells such that high affinity variants are preferentially selected while low affinity or self-
reactive clones are eliminated by apoptosis (Hoch et al., 2000; Shokat and Goodnow, 
1995; Smith et al., 2000; Takahashi et al., 1999). Follicular B helper T cells (T,.H) are 
responsible for supporting Ig production and probably selecting high affinity mutants 
(Liu et al., 1989). Selected cells can then go on to differentiate into either memory B 
cells or long-lived plasma cells, which generally home to the bone marrow. 
1.1.2 T helper subsets 
The differentiation of CD4 T cells into T helper subsets determines whether humoral or 
cell-mediated immunity will predominate, and regulates B cell differentiation, selection, 
and activation of other effector cell types including macrophages. All T helper subsets 
express the C D 4 co-receptor and recognize fragments of antigens degraded within 
intracellular vesicles, displayed at the cell surface by M H C class II molecules. 
There are at least four subsets of CD4"' helper cells: Thl , Th2, Thl7, Ti n; and at least 
three of them (Thl, Th2, TIH) can provide help to B cells (Harrington et al., 2005; 
Mosmann and Sad, 1996; Vinuesa et al., 2005b): 
1.1.2.1 Thl cells: 
These cells control infection with intracellular pathogens, including viruses and bacteria 
(Sher and Reis e Sousa, 1998; Thierfelder et al., 1996). Thl cell differentiation requires 
IL-12 secretion by antigen-presenting cells (APCs) and the T cell transcription factors 
T-bet. STAT4 and STATl (Szabo et al., 2000). Thl cells secrete IFN-y and tumor 
necrosis factor (TNF), and induce mouse B cell switching towards IgG2a (Cher and 
Mosmann, 1987; Stevens et al., 1998) Thl cells have been thought to mediate many 
autoimmune diseases although a number of them now appear to be mediated by Thl 7 
cells instead (Furuzawa-Carballeda et al., 2007; Weaver et al., 2006) 
1.1.2.2 Th2 cells: 
Th2 cells control infection with helminths and other extracellular microbes and are, in 
part, the effectors that mediate the immunopathology of allergic responses and asthma 
(Janeway et al., 2004). Th2 cell differentiation requires the cytokine IL-4 produced 
during T cell priming by APCs (and mast cells), and the T cell transcription factors 
STAT6 and GATA3 (Ansel et al., 2006; Kaplan et al., 1996; Zheng and Flavell, 1997). 
Th2 cells secrete IL-4, IL-5, and IL-13, and induce B cell switching predominantly to 
IgGl (in mice) (Mosmann and Coffman, 1989; Stevens et al., 1988). 
1.1.2.3 Tfh cells: 
TI H cells localize to the follicles and typically express the highest levels of ICOS and 
the chemokine receptor CXCR5, which binds CXC-chemokine ligand 13 (CXCL13) 
that is a chemokine that is secreted by follicular stromal cells and TIH cells themselves 
(Breitfeld et al., 2000; Hutloff et al., 1999; Kim et al., 2001; Schaerli et al., 2000). They 
are specialized in providing help to germinal center 8 cells during antibody responses to 
T cell-dependent antigens (reviewed in (Vinuesa et al., 2005)). They also express the 
transcription factor Bcl-6 and B cell co-stimulatory molecules including CD40L and IL-
21 (Chtanova et al., 2004). 
1.1.2.4. Thl7 cells: 
Thl7 cells appear to protect against fungal antigens, secrete IL-17 (both IL-17A and IL-
17F) and expand in response to IL-23 independently of T-bet or STATl but dependent 
on STAT3 (Acosta-Rodriguez et al., 2007; Harris et al., 2007; Yang et al., 2007). In 
mice, polarization of naive CD4"^ T cells toward the Thl 7 lineage requires a combination 
of T cell antigen receptor (TCR) stimulation, the cytokines TGF-p, IL-6 and IL-21 
(Korn et al., 2007; Nurieva et al., 2007; Zhou et al., 2007), and expression of the 
transcription factor RORyt (Ivanov et al., 2006). Thl7 cells have been shown to mediate 
organ-specific autoimmune diseases including experimental allergic encephalomyelitis, 
collagen-induced arthritis, and inflammatory bowel disease (Langrish et al., 2005; Park 
et a l , 2005; Weaver et al., 2007) 
1.1.3 TFH cells and autoimmunity 
Immunity is controlled by checks and balances. Evidence from a number of studies 
indicates that self-antigens are abundant in germinal centers. In particular nuclear 
antigens are known to be exposed on the surface of apoptotic cells in the form of 
membrane blebs (Casciola-Rosen et al., 1994). 
Since B cells undergo somatic hypermutation within germinal centres that can 
potentially give rise to the emergence of self-reactive B cells, tolerance check-points 
must be in place to eliminate B cells with self reactive specificities. In principle this can 
be achieved by preventing activated self-reactive T cells entering follicles and providing 
help to self-reactive germinal center B cells (Vinuesa et al., 2005). In this way, self-
reactive germinal center B cells will be precluded from differentiation to become 
plasma cells and memory cells (Goodnow et al., 2005). There are two mechanisms that 
have been described that curtail self-reactive T J H from providing aberrant help to self-
reactive B cells. The first mechanism depends on CD4'^CD25"^CD69" regulatory T cells 
(Tregs) (Lim et a l , 2004). In the second mechanism, the Roquin pathway appears to 
repress accumulation of self-reactive T cells within germinal centers (Vinuesa et al., 
2005a). 
1.2 Co-stimulation: signaling and its regulation 
1.2.1 Families of co-stimulatory signals 
Importantly, naive T cells require two signals for full activation (Janeway et al., 2004). 
The first is antigen-specific and based on recognition of peptide/ MHC complexes by 
the T cell receptor (TCR). The second signal is an antigen non-specific co-stimulatory 
signal, delivered by molecules expressed on the surface of antigen presenting cells 
(APCs). 
T cell activation and function is regulated by the innate and adaptive immune systems, 
through positive and negative co-stimulatory signals (Greenwald et al., 2005). The best 
described co-stimulatory molecules belong to the B7 superfamily. B7 ligands are 
expressed by APCs (dendritic cells, B cells and macrophages) and play key roles in 
regulating T cell activation and tolerance (Sharpe and Freeman, 2002). Manipulation of 
co-stimulation has promising therapeutic value in a number of autoimmune and 
inflammatory conditions. These pathways not only provide critical positive second 
signals that promote and sustain T cell responses, but they also contribute critical 
negative second signals, such as through CTLA-4 and PD-1 that down-regulate T cell 
activation (Carreno and Collins, 2002). These negative signals function to limit, 
terminate, and/or attenuate T cell responses, and they appear to be especially important 
for regulating T cell tolerance and autoimmunity (Abbas et a l , 2004). 
1.2.2 The CD28/CTLA 4 family 
The CD28 family of co-stimulatory molecules expanded with the discovery of T cell 
Inducible Co-Stimulator (ICOS) in 1999 by Kroczek and colleagues (Hutloff et al., 
1999). In this super family, ICOS, CD28, cytotoxic T lymphocyte antigen 4 (CTLA-4), 
and programmed cell death protein (PD-1) share several structural and functional 
similarities (Sharpe and Freeman, 2002). The B7-CD28/CTLA-4 co-stimulatory 
pathway is the best characterized T cell co-stimulatory pathway and is complex because 
of the dual specificity of B7-1(CD80) and B7-2(CD86) for the stimulatory receptor 
CD28 and inhibitory receptor CTLA-4 (CD 152) (Greenwald et al., 2005). CD28 
delivers signals important for T cell activation and survival; in contrast CTLA-4 inhibits 
T cell responses and regulates peripheral T cell tolerance (Burmeister et al., 2008; 
Greenwald et al., 2005). ICOS is inducibly expressed on T cells upon priming, and 
plays important roles in the development and/or effector function of, Th l , Th2, TI H cells, 
CD8"' cytotoxic T cells and Treg cells (Akbari et al., 2002; Greenwald et al., 2005; 
Hutloff et a l , 1999; Burmeister et al., 2008). 
CD28/B7; ICOS/ICOSL and CD40L/CD40 interactions are known to be necessary for T 
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cell-dependent antibody production, isotype switching, and germinal center formation 
(Sharpe and Freeman, 2002). Humans and mice deficient for any of these 
ligand/receptor pairs exhibit absent or impaired germinal center formation, B cell 
memory production and production of switched antibody. While defects in 
CD40/CD40L and B7/CD28 signaling affect earlier stages in the immune response 
including T cell priming, the effects of ICOS deficiency or deficiency of its ligand are 
more confined to the impairment of germinal centre responses (Dong et a!., 2001a; 
Dong et al., 2001b; Mak et al., 2003; McAdam et al., 2001; Tafuri et al., 2001; Wong et 
al., 2003) 
1.2.3 The Icos gene 
In humans, Icos is located on chromosome 2q33 in a tight cluster with CD28, CTLA4. 
and PD-1. Interestingly, this region has been associated with both autoimmune and 
hypersensitivity diseases such as multiple sclerosis, systemic lupus erythrematosus 
(SLE), and asthma, all of them are associated with potentially pathogenic antibody 
responses (Coyle and Gutierrez-Ramos, 2004; Graham et al., 2006). 
ICOS consists of five exons with 2620 nucleotides (NM_0I2092) coding for a 199 
amino acid protein. The 5 prime untranslated region (5'UTR) of ICOS is 35 nucleotides 
in length and the coding region is 600 nucleotides long (from 36 to 635 bps). The 
3'UTR is 1895 nucleotides long (from 636 to 2620 bps). 
1.2.4 The ICOS/ICOSL pathway 
As mentioned above, the ICOS: ICOSL pathway appears to be particularly important for 
stimulating effector T cell responses and T cell-dependent B cell responses. In naive T 
cells that do not express ICOS, ICOS is upregulated upon T cell priming (Hutloff et al., 
1999). The highest levels of ICOS are found on T™ cells, in fact ICOS"'®*" expression is 
one of the most reliable phenotypic features of this subset (Vinuesa et al., 2005). All 
other effector CD4'' cells besides TIH cells also express ICOS, albeit lower levels 
(Yoshinaga et al., 1999). Expression of ICOS by Tregs has been suggested to be 
important for their suppressor function (Akbari et al., 2002). Although ICOS levels 
persist at higher levels on Thl cells than they do on Th2 cells (Greenwald et al., 2005), 
there is evidence to suggest ICOS expression is more critical for Th2 function rather 
than for Thl (Hutloff et al., 1999). 
In a manner similar to CD28, ICOS signaling augments T cell activation during effector 
responses and cytokine production. In the absence of CD28, ICOS can compensate and 
allow sufficient co-stimulation for immune responses to take place (Suh et al., 2004). As 
mentioned above, ICOS-ICOS-L interactions also provide critical signals for B cell 
differentiation into memory cells within germinal centers and maintain TFH cell 
longevity (Akiba et al., 2005). 
Mice deficient in ICOS have poor T-dependent antibody responses with impaired 
germinal centre formation, and very low numbers of switched and memory B cells 
(Dong et al., 2001b; McAdam et al., 2001; Tafuri et al., 2001). Humans with mutations 
in ICOS suffer from common variable immunodeficiency (CVID) and lack memory B 
cells (Grimbacher et al., 2003). Thus, ICOS signaling guarantees the longevity of 
humoral immune responses. 
1.2,5 ICOS signaling in autoimmunity 
While ICOS deficiency leads to T and B cell immunodeficiency (Grimbacher et al., 
2003), several studies suggest that dysregulated ICOS signaling may lead to 
autoimmunity. Blockade of ICOS-ICOS-L interactions have been shown to ameliorate 
autoantibody-mediated autoimmune disease in mice (i.e. collagen-induced arthritis, 
experimental allergic encephalomyelitis and lupus-like syndromes) (Iwai et al., 2003; 
Iwai et al., 2002; Rottman et al., 2001). Overexpression of ICOS-L using an ICOS-L-Fc 
transgenic led to hypergammaglobulinemia (Yoshinaga et al., 1999), although there was 
no report of autoimmunity in these mice. Human patients with lupus and rheumatoid 
arthritis have been reported to express high levels of ICOS on their T cells (Hutloff et al., 
2004; Kawamoto et al., 2006; Okamoto et al., 2003; Yang et al., 2005), but until now it 
has been unclear whether this is a cause or an effect. More recently, sanroque mice, 
carrying a mutant form of Roquin (Roquin" '^^ * '^^ ) have been shown to overexpress ICOS 
in a T cell autonomous fashion, and develop systemic autoimmunity (lupus) and organ-
specific autoimmunity (autoimmune diabetes). During the course of this work, our 
laboratory has established that Roquin'^'^^'^-induced ICOS overexpression is directly 
responsible for the lymphadenopathy, splenomegaly, and T and B cell accumulation 
found in sanroque mice (Yu et al., 2007). In summary, ICOS appears to play an 
important role in the maintenance of self-tolerance, and thus understanding its 
regulation is potentially important for the improved diagnosis and treatment of several 
autoimmune diseases. 
1.3 The novel immune regulator Roquin 
The Roquin gene was identified during a search for novel autoimmune regulators in the 
mouse genome (Vinuesa et al., 2005a; Vinuesa and Goodnow, 2004). As mentioned 
above, scmroque mice homozygous for a mutant allele of Roquin {san\ M199R) develop 
lupus-like disease. The human Roqitin/RcShl gene can be found on chromosome 1 
within the lq25 locus. Roquin consists of 20 exons. The transcript length is 4,094 bps 
and the translated product is 1,133 residues. The Roquin protein is highly conserved 
across species. It contains an amino-terminal RING-1 zinc-finger at residues 14-53 that 
conforms perfectly to the consensus for the E3 ubiquitin ligase family of proteins. From 
residues 131 to 360, there is a novel protein domain named ROQ domain, which 
harbours the M199R mutation found in sanroque mice. A zinc-finger motif of the C-Xg-
C-X5-C-X3-H type (CCCH type zinc finger) where X is any amino acid, occurs distal to 
the ROQ domain, from residues 419-438 (Vinuesa et al., 2005a). Roquin also contains a 
large proline-rich region, predicted to contain multiple binding sites for SH3 domain-
containing proteins, and two coiled-coil domains that may mediate dimerisation of this 
protein. 
1.3.1 The structure of Roquin protein 
R I N G l C C C H Proline-rich Coiled-coil 
ROQ I I 
(Vinuesa et al., 2005a) 
1.3.1.1 Structure and function of Zinc finger motifs 
The name "zinc finger" was coined based on a two-dimensional diagram of a typical 
domain structure resembling a finger and these proteins have multiple copies of folded 
domains that contain conserved cysteines and histidines binding to zinc. The zinc-finger 
motif is an important group of DNA-binding motifs with one or more zinc atoms as 
structure components. There are several different types and combinations of Cys-Cys 
(CC) or Cys-His (CH) motifs that comprise the zinc finger family, which is found in 
over 100 transcription factors, E3 ubiquitin ligases, and RNA-regulating proteins. I will 
briefly describe the two zinc fingers that are found in Roquin. 
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1.3.1.2 RING type zinc finger motif 
The first report of a RING finger motif was published in 1991 by Freemont and 
colleagues. Initially, the motif was identified by searching sequence databases and using 
the N-terminal sequence of a gene named RINGl (really interesting new gene 1). 
Within the past twenty years, the three-dimensional structure and biological function of 
the RING finger motif has become apparent. 
The RING finger motif is a C3HC4 zinc-finger motif and can be defined as C-X2-C-X 
(„,-45rC-Xi-C-X7-H-X2-C-X(u-25)-C-X2-D (Koken et al., 1995). Roquin's RING motif 
conforms perfectly to the consensus for the E3 ubiquitin ligase family of proteins 
(Pfam00642) , which includes Lnx, Traf 4, Rbx and Cbl. Roquin's RING finger motif 
has recently been shown to have an ubiquitin ligase activity: the C.elegans homologue 
of Roquin, RLE-1, mediates ubiquitylation of DAF-16 via its RING finger motif (Li et 
al., 2007). 
Ubiquitination generally targets proteins for degradation in the proteasome, although it 
can also mediate recycling of membrane-bound proteins and direct them to lysosomal 
compartments. RING finger proteins such as IVIDIVI2, c-Cbl, or BRCAl, have been 
shown to play a critical role in degradation of regulatory proteins. Some of these 
proteins regulate cellular proteins that prevent tumorigenesis. Some reports have shown 
that faulty RING finger proteins are implicated in human cancers and autoimmune 
disorders (Bachmaieret al., 2000; Fang et al., 2003; Harris. 2005; Sigalas et al., 1996). 
1.3.1.3 CCCH Zinc finger motif 
In recent years, some studies identified that Cys-Cys-Cys-His (CCCH)-containing 
proteins are involved in the post-transcriptional control of gene expression. CCCH zinc 
finger motifs can bind to RNA and destabilize it (or in less frequent cases, stabilize it) 
via AU-Rich- Elements (ARE) present in the target RNA sequence (Carballo et al., 
1998; Carrick et al, 2004). Roquin's CCCH motif is shared by tritetraprolin (TTP), Pos-
1, CPSF30K/Ythlp, TbZPl and TcZFPl (Carballo et al., 1998; Carrick et al., 2004; 
Taylor et al., 1996). Recent evidence suggests the CCCH motif can help the accelerate 
mRNA degradation by enhancing the mRNA decay process initiated after removal of 
the polyadenylated (polyA) tail from mRNA. In this way, TTP mediates ARE-
dependent Tnf mRNA degradation (Blackshear, 2002). RNA-binding proteins 
containing CCCH-Zinc fingers can also regulate post-transcriptional regulation of gene 
expression at the level of translation. 
1.3.1.4 The novel and highly conserved ROQ Domain 
The novel protein Roquin contains an extraordinarily conserved novel domain, named 
ROQ domain (Vinuesa et al., 2005a). This domain appears to be critical for Roquin's 
localization to stress granules and for the induction of stress granule formation upon 
Roquin overexpression (Athanasopoulos V, personal communication). It is in this 
domain where Roquin's mutation responsible for the lupus phenotype of sanroque 
mice lies. 
1.4 The regulation of ICOS expression 
1.4.1 Transcriptional regulation 
The critical role of ICOS in co-stimulating T cell responses is well documented. As its 
name indicates ICOS is induced during T cell activation. However, there is not much 
knowledge about the mechanisms that regulate ICOS expression. A recent study using 
signal pathway-specific inhibitors has shown that the transcription of Icos was enhanced 
by the signals through Fyn-calcineurin-NFATc2 and MEK2-ERK1/2 pathway (Tan et al., 
2006). 
1.4.2 Post-transcriptional regulation 
Although there is as yet no evidence that ICOS expression is regulated post-
transcriptionally, the localization of Roquin to SGs, a hub of mRNA decay and 
translational inhibition, and its putative RNA binding CCCH domain suggests the 
possibility of post-transcriptional regulation of ICOS. 
Recent studies have highlighted the critical role of the regulation of mRNA turnover to 
enable cells including T lymphocytes, to rapidly respond to environment stimuli by 
changing the amounts of critical mRNAs encoding cytokines and chemokines (Cheadle 
et al., 2005; Fan et al., 2002). The rapid decay of mRNA is determined by specific r e -
acting elements. Among them, AU-rich elements (AREs) have been found and 
functionally characterized (Brooks et al., 2004). As mentioned above, TTP can regulate 
mRNA stability of Tn/via its 3 'UTR containing AREs (Blackshear, 2002; Carballo et 
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al., 1998). 
Besides ARBs, other cis-acting elements that regulate mRNA translation and stability, 
such as microRNA (miRNA), have also been identified. The first miRNA, lin-4, was 
found in 1993 (Lee et ai, 1993). MiRNAs have attracted attention as a new class of 
small non-coding RNAs regulating the expression of genes that are involved in various 
biological processes, such as development, cell proliferation, and apoptosis 
(Kloosterman and Plasterk, 2006; Lee et ai, 2004; Wienholds and Plasterk, 2005). 
MiRNAs have been shown to bind miRNA target sequences within the 3 'UTR of target 
mRNAs and mediate post-transcriptional repression of gene expression (Jackson and 
Standart, 2007). The number of known miRNAs in mammals has risen dramatically, and 
their total number in humans has been predicted to be as high as 1,000 (Berezikov and 
Plasterk, 2005; Chang and Mendell, 2007). 
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Materials and methods 
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2.1 Recombinant DNA techniques 
2.1,1 Vectors 
2.1.1.1 Vector information 
The schematic map of pR-IRES-huCD4 retroviral vectors is shown below. 
Nhel Kpul 
5'LTR(MSCV) 
Unique sites in the MCS 
Bgm 
Xhol 
SnU 
EcoRI 
IRES 
pR-IRE5-huCD4 
huCD4 
3'LTR (MSCV) 
Kpul 
Ncol 
BainHI 
Nhel 
Multiple cloning site (MCS) sequence 
Bgl II Xho I Sal I 
AGATCTCTCGAGGTCGACGGTATCGATAAGC 
EcoR I 
TTGATATCGAATTCCGCCCCCCCCCCTAACG 
TTACTGGCCGAAGCCGCTTGGAATAAGGCC 
GGTGTGCG 
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2.1.1.2 Preparing pR-IRES-huCD4 retroviral vector for Icos cDNA subcloning 
pR-IRES hCD4 retroviral vector (1 |ig) was digested for 3 hours at 37°C with the 
restriction enzymes Bgl II (1 and Xho 1(1 nl) in a 20|al reaction mix. 
pR-1 FES- huCm vecot r (0. 5 |j g/ p 1) 2 p 1 
Bgl • ( h t w &igl and B ol abs, 1 psv\i ch, UB^ 1 M 1 
XhoD (ISbw BngI and B ol abs, 1 psw ch, UBA) 1 M 1 
But f er 2( l ^w Bigl and B ol abs, 1 psw ch, UB^ 2 p 1 
Dei oni sed m \ er (ddHQ 14 p 1 
The digested vector was isolated on a 1% (w/v) agarose gel (Amresco, Solon, OH, 
USA). A 1% gel was prepared with 1 x TAE buffer. Samples were loaded into the wells 
with 5 1^1 loading dye and run in 1 x TAE buffer at 150V for 30 minutes. The gel was 
stained in 1^1/ml ethidium bromide for 30 minutes. Digestion products were visualized 
under UV light using Gene Genius Bioimaging system (SynGene, Fredrick, MD 21704, 
USA) and gel images were taken using GeneSnap software (Syngene). 
The expected sized fragments were excised from the gel with a sterile sharp scalpel 
(Swann-Morton, Sheffield, UK) and purified using the QIAquick gel extraction kit 
(QIAGEN, VIC. Australia). The gel slices were solubilized by incubating in buffer QG 
at 50°C for 10 minutes, and then they were applied to the column and centrifuged at 
13,000 rpm for 1 minute in a microcentrifuge (Sigma Quantum Scientific). The column 
was washed with PE buffer by centrifuging at 13,000 rpm for 1 minute. Then the DNA 
was eluted by adding 20^1 elution buffer to the column and centrifuging at 13,000 rpm 
for 1 minute. 
2.1.2 Icos cDNA fragments 
2.1.2.1 PGR amplification of Icos from cDNA template 
The oligonucleotide primers used to amplify Icos cDNA fragments and expected 
product sizes are listed below. The sequences are denoted 5' to 3' . 
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Cbdi ng sequence (CCQ 
Forvvard AM A3MCR TTC TOG A\A/^CA TQ\ A3 TCA G 
pri n®r 
Ffeverse AAA crc G^G OA\ G^G TTC A\T ATT ATA GOG TOV 
pri rrer 
FVoduct size 624 bps 
Ful I I engt li (PL) 
Fbrvvard AAAAQ^ TCTC^ GAACGDG^ 3GAC^ G^ TA 
pri rr®r 
Ffeverse AAA CTC QSG Ta\ AAT GIT TAT TCT TTG CUT TCT T 
pri r«Br 
R-cxIuct size 2596 bps 
Ful I I engt h I acki ng F2 andF3 (A F2+R3) 
Forward AAAAQ^ TCrCrGAflCGDGAGGACrGTTA 
pri rt®r 
Ffeverse AAACrCGaGAAAACrATTQaGG0GGfiGAG3lA 
pri rer 
R-oduct size 1348 bps 
Ful I I engt h I acki ng F3 (A F3) 
For v\ard pri rrer AAAAQ\TCTCTGAA3GD3A3GACrGITA 
Ffever SB pr i n®r AAA CTC GOG CTG TG^  TTOOGflGQSTQO" 
Roduct size 1884 bps 
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F1 of 3' U r R ( 3 ' U I R F 1 ) 
Fbr\ f tard p r i ner AAA A Q M C r TQ\ O X TAT A^T ATG GN\ CTC TGG 
Fteverse p r i rrer AAACrCQaGA^ACrATTQaGCf lGCAGAGGA 
R-cxiuct s i z e 724 bps 
F2 of 3' UTR ( 3 ' UTB F2) 
For\Aard AAA AG^ TCr TGC TCT O J OCT GAA TAG TTTT 
p r i n®r 
Ftever s e AAA c r c G^G CTG TG^ TTOOGfla3GrG0Cr 
p r i rrer 
R- oduct si z e 558 bps 
F3 of 3' UTR ( 3 ' UTR F3) 
Fbrv \ard AAA AG^ TCT CTC CD\ G^G OCT G<W GTC AC 
p r i rrer 
Fteverse AAA c r c G^G TO\ AAT GTT TAT TCT TTG OCT TCT T 
p r i rrer 
FVoduct s i z e 763 bps 
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PCR reaction mix: 
10 X R u b u f f e r ( S l r a t a g e n e ) 5 M 1 
dNTFfe (10ni/ldATP, dCTP, dGIP and dl Ih) 1 M 1 
Forvvard 0 1 gonuci eot 1 de pr 1 ner (10 |j M Gfene wDrks) 1 M 1 
Forvvard 0 i gonuci eot 1 de pri n®r {10 p M Gfene w)rks) 1 M 1 
c m tenpl a t e (10 ng /p 1) 1 M 1 
R u DSKV pol yn®rase ( 3 rat agene) 1 M 1 
De i oni s ed vat er (ddKQ 40 M 1 
PCR thermal program: 
Step Tenperature DUrati on cycle 
R e - d e n a t u r e 94D 120 ( sec) 1 
Dfenat ur e 94a 30 ( sec ) 
Anneal i ng 6 0 3 30 ( sec ) 30 
B ongat 1 on 683 60 ( sec) / kb 
/V t er - el ongat i on mn 300 ( sec) 1 
2.1.2.2 Restriction enzyme digestion of PCR products 
PCR products were separated on a 1% (w/v) agarose gel. The bands with expected size 
were excised from the agarose gel and purified using QIAquick gel extraction kit. 
The gel purified fragments were restriction digested for 3 hours at 37°C with Bgl II (1 
^1) and Xhol (1 ^1): 
Rjri f 1 ed PCR product {Icos cC^I^ f rangrrents) 
Bgl • (r^few Bigl and B ol abs, I psw ch, UB^ 
XhoD (l^few Bigl and B ol abs, I psw ch, UB^ 
Buf f er 2( Nsvj Bigl and B ol abs, I psw ch, LB^ 
Dei oni s ed v\at er (ddHQ 
5 |j I 
1 M I 
1 M I 
2 M I 
11 U 
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2.1.2.3 Purification of DNA fragments 
After the reaction was performed the digestion production was run via electrophoresis 
on a 1 %(w/v) agarose gel. The bands with expected size were excised from the agarose 
gel and purified using QIAquick gel extraction kit. 
2.1.3 Generation of new retroviral constructs expressing different Icos cDNA 
fragments 
2.1.3.1 Insertion oilcos cDNA fragments into pR-IRES-huCD4 retroviral vector 
A ligation reaction was performed to insert Bgl-II-Xho-I digested Icos cDNA fragments 
into Bgl-II and Xho-I digested pR-IRES-huCD4 vector. 
Bgl II and Xho I - di gest ed pR I FES- huCC4 vect or 3 |J I 
(700M g) 
Bgl II and Xho I -d igested / c o s cCN^ f ragrrents 14 |j I 
(800|j g) 
T4 [ M I i gat i on buf f er (Fbche di agnose) 2 fj I 
T4 CN^ I i gase (Fbche di agnose) 1 I 
The ligation reaction mix was incubated overnight at 16°C 
2.1.3.2 Chemical transformation of competent cells 
DH5a E.coli competent cells were heat-shocked in the presence of ligated products. 
The 20|al ligation reaction mix and lOOjiL DH5a competent cells (homemade) were 
incubated together on ice for 20 minutes and then shocked by incubation at 42°C for 60 
seconds, followed by incubation on ice for 15 minutes. 250|xl LB broth was added to 
the tube and incubated at 37°C with rigorous shaking for 45 minutes. The cells were 
spread on an ampicillin agar plate which would only permit growth of ampicillin-
resistant cells, which is cells, containing the pR-IRES-huCD4 vector, which carry the 
ampicillin resistance gene. The agar plates were incubated overnight at 37°C. 
2.1.3.3 Mini preparation of plasmid DNA (mini-prep) 
Individual colonies were then selected and cultured overnight in LB broth with 
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ampicillin (lOOng/ml). Plasmids were isolated from the cultures using QIAprep kit 
(QIAGEN, VIC, Australia) as per the manufacturer 's instructions. Cultured cells were 
pelleted by centrifugation at 4000 rpm for 1 minute; the cells were resuspended in 
250|xl PI buffer and transferred to a 1.5ml Eppendorf tube (Hamburg, Germany). 
Buffer P2, 250^1, was added and the tube mixed by inversion. 350^1 of buffer N3 was 
added and the tube was mixed by inversion. The cellular debris was pelleted by 
centrifugation at 13,000 rpm for 10 minutes in a microcentrifuge (Sigma Quantum 
Scientific). The supernatant was applied to a QIAprep column and centrifuged for 1 
minute at 13,000 rpm. The column was washed with 0.7 ml of buffer PB by 
centrifugation at 13,000 rpm for 1 minute. The DNA was then eluted with 50[iL elution 
buffer by centrifuging for 1 minute at 13,000 rpm. 
2.1.3.4 Large scale preparation of plasmid DNA (maxi-prep) 
Plasmids were isolated from the cultures using Hurricane Maxi Prep Kit 
(GerardBiotech, US) as per the manufacturer's instructions. The culture was shaken at 
250 RPM over night at 37°C until cell density was no more than OD.s95<l-3 and 
transferred to a 250ml centrifuge (Sorvall) tube. After centrifugation for 10 minutes at 
5,000 X g at room temperature, the bacterial pellet was resuspended in 10 ml of Buffer 
A by pipetting. The resuspension was transferred to a 50 ml disposable centrifuge tube 
and 10 ml of Buffer B added. The suspension was mixed by inverting the tube 10 times 
and allowed to stand at room temperature for 5 min. To this, 13 ml of Buffer C was 
added and mixed by inversion 10 times. The mixture was transferred to a high speed 
centrifuge tube and centrifuged for 10 min. at 14,000 - 18,000 x g at 4 °C. The 
supernatant was carefully transferred to a 50 ml disposable centrifuge tube and kept at 4 
°C. The supernatant was added to the DNA Binding Column Unit and centrifuged for 5 
min. at 5,000 x g at 4 °C to bind the DNA. After discarding the liquid from the 
collection tube, the remaining supernatant was added to the column and re-centrifuged. 
The excess liquid was discarded and the DNA bound to the column was washed with 20 
ml of 70% ethanol and centrifuged at 5,000 x g for 5 minutes at 4 °C. The ethanol wash 
was repeated. Any excess ethanol was removed from the centrifuge tube by 
centrifugation (10 min, 5,000 xg, RT) and air drying the column for 10 min. The DNA 
binding column was carefully transferred into a new 50 ml collection tube. To elute the 
DNA from the column, 1ml of heated ddH20 was added to the column and left at RT 
for 1 min. The column was centrifuged for 5 min at 5000xg at RT. Plasmids were stored 
at -20°C. 
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2.1.3.5 Quantitation of DNA 
The preparation of plasmid DNA was quantified using NanoDrop. The concentrations 
of DNA samples from maxi-preps usually range from 500ug/ul to 1500ug/ul; the 
concentrations of DNA samples from mini-preps usually range from 200ug/ul to 
400ug/ul. 
2.1.3.6 DNA sequencing 
The oligonucleotide primers used to sequence HulCOS FL contructs are listed below. 
The sequences are denoted 5' to 3'. 
Forvard C r o G ^ A T C ^ O Q ^ i T r c 
pri rrer 
Ffeverse /aCTOGaGV^GDWGDCJGr 
pri n®r 
Sequencing PCR reaction mix: 
5 X sequenci ng buff er ( B ortiDl ecul ar Ftesource Fiaci 11 ty , 4 M 1 
AN4 
Forv\ard 0 1 gonuci eot 1 de pri n®r {10 p M Gfene vvorks) 2 M 1 
c m tenpl a t e (10 ng/p 1) 5 p 1 
B g dye t er rrii nat or ( B on®! ecul ar Ffesour ce Fad 111 y, 1 M 1 
J f T ^ AN4 
Dfei oni sed \Aat er ( d dKQ 6 M 1 
After preparing the reaction mixture, each sample was performed in a 200|il thin-
walled 96-well plate (Quality Scientific Plastics) using a MJ Research PTC-225 Peltier 
Thermal cycler. 
20 
PGR thermal program: 
S e p Tenpera ture DUrati on Cycl e 
F^e-denat ure 96° 0 300 (sec) 1 
Denat ur e 96° 0 30 (sec) 
Aineal 1 ng 50° 0 15 (sec) 30 
B ongat 1 on 60° C 90 (sec) 
/Vt er-el ongat i on 60° C 240(sec) 1 
The sequencing products were precipitated for submission. The samples were 
transferred to a 1.5ml tube and l|.il EDTA (50mM), 50|^ 1 absolute EtOH and l|al 
NaOAc (1.51VI) were added. After centrifugation at 13000 rpm for 30 minutes at room 
temperature, the supernatant was removed carefully. The pellet was washed with 250|il 
70% ethanol and centrifuged at 13000 rpm for 15 minutes at room temperature. The 
supernatant was removed and pellet washed again. Then, the DNA pellet was dried by 
centrifugation under vacuum and submitted for sequencing. 
2.2 New retrovirus constructs 
2.2.1 Cell culture 
Phoenix cell line 
The Phoenix cell line is derived from HEK293T cell line and is used for retroviral 
packaging. This cell line was cultured in complete Dulbecco's Modified Eagles 
Medium (DMEM) (SAFC, Bioscience, USA) supplemented with 2% PSG and 10% HI-
FCS and at 37°C, with 5% CO2. 
NIH 3T3 cell line 
The NIH 3T3 cell line is a mouse embryonic fibroblast cell line. This cell line was 
cultured in complete DMEM (SAFC, Bioscience. USA) supplemented with 2% PSG 
and 10% HI-FCS and at 37°C, with 5% CO2. 
2.2.2 Packaging of retroviruses 
The retroviruses expressing either Roquin, Icos cDNA fragments or empty vector were 
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packaged in Phoenix cells by transfecting Phoenix cells with individual constructs. One 
day before transfection, Phoenix cells growing in culture were split and added 4 x 1 0 ^ 
cells into a new 160ml tissue culture flask (Nunc, Roskilde, Denmark) and the cells 
incubated overnight at 37°C in 20ml DMEM (JRH biosciences, VIC, Australia) until 
they were 70-80 % confluent. The culture medium was replaced after 30-40 minutes 
with 10ml DMEM with 25nM chloroquine and incubated at 37°C. For the transfection, 
2500 |il transfection mix (1250 2 x HBS buffer, 25-30^g of the plasmid diluted in 
1000|il sterile H2O and 250 |j.l calcium chloride (1.25 M)) was added drop-wise to the 
phoenix cell culture flask and cells were incubated at 37°C. Fresh DMEM was added 6 
hours after transfection to replace the transfection media. The cells were incubated for 
24 hours at 37°C, and then at 30°C for another 24 hours. The culture supernatant 
containing retroviral particles was harvested and stored at -80 °C. 
2.2.3 Retroviral transduction 
NIH3T3 cells were cultured at 2 x 10^ per ml in DMEM (SAFC, Bioscience. USA) for 
24 hours, and then spin-co-transduced with retroviral supernatant containing 40 ul/ml 
polybrene (Sigma, Germany) in six wells plates (NUNC, Denmark) at 30°C and 
2500rpm for 90 minutes. After 2 hours the media in each well with transduction 
reagents was replaced with fresh media, and then incubated in 37 • for another 48 
hours. 
2.3 RNA extraction 
Cell pellets are stored at -70 °C in Trizol (Invetrogen, USA). All RNA work is done in a 
specified RNA room under sterile conditions. This involved taking precautions to avoid 
RNA degradation by Rnases. After allowing the Trizol samples to thaw out, they are left 
for 10 minutes at room temperature. 0.2 ml of Chloroform per 1ml of Trizol is added to 
each tube and tubes are shaked vigorously for 15 seconds. The samples are then 
incubated at room temperature for 2-3 minutes and then centrifuged at 14,000 rpm at 
4°C for 10 minutes. After spinning three separate layers should be visible, the 
eppendorf tube is held against a light source to clearly see three different layers. The top 
layer is Chloroform, containing RNA; the middle layer contains debris of proteins and 
DNA while the bottom layer is Trizol. The top layer containing the RNA is carefully 
aspirated, trying not to aspirate any of the middle layer. The layer is transferred into a 
fresh sterile eppendorf tube. Adding 0.5ml of isopropanol and l|.d of linear acryl amide 
to precipitate out the RNA. The samples are then shaked and incubated for 10 minutes 
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on ice and then centrifuged as before for 10 minutes. A pellet should be visible at this 
stage. The supernatant is discarded without taking up the pellet. 1ml of 75% ethanol is 
added. The tube is briefly vortexed and centrifuged for 10 minutes. Then all the ethanol 
in the eppendorf tube is removed and the pellet dried at 45°C for 1 minute or at room 
temperature for 10 minutes. The pellet is then resuspended in lO^l of DEPC treated 
H2O and incubated at 55°C for 10 minutes. 
2.4 cDNA synthesis 
The cDNA synthesis reaction was prepared as follows using Invitrogen reagents 
0 1 go cTT 1 M 1 
5 X b u f f e r 4 p 1 
Ul 1 ( 0 . 1 M 2 p 1 
dNIhfe 1 M 1 
R\bse 1 nhi bi t or 0. 5 p 1 
l\M.V- S u p e r s c r i p t 1 M 1 
Tenpl at e F m 10 p 1 
The samples were incubated at 65°C for 10 minutes and then cooled on ice for 1 minute. 
Then 9ul of mix was added to all samples and rapidly pelleted at 4°C. The samples 
were incubated at 42°C for 1 hour and then 90°C for 10 minutes on the heat block and 
cDNA was stored at -70°C. 
2.5 Real-Time PCR 
S t e p 
1 
2 
3 
4 
T e n p e r a t u r e 
5on 
9 5 0 
95n 
6 0 3 
DUrati on 
120 ( s ec ) 
600 ( s ec ) 
15 ( s ec ) 
60 ( s ec ) 
Cyc le l^b. 
1 
40 
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2.6 Flow Cytometry 
NIH3T3 cells were collected in FACS wash buffer and subsequently centrifuged at 4 °C 
for 4 minutes using a Heittich Rotana 460R centrifuge. Following this, the cell 
suspension was plated out to a round-bottom 96 well plate (NUNC, Denmark). Cells 
were then washed with 100|il FACS wash buffer and incubated at 4 °C for 30 minutes 
with primary antibody (Table 1.1), which was suspended in 50 |il FACS wash buffer. 
Following incubation, the cells were again centrifuged and washed with FACS wash 
buffer. If necessary, secondary antibody (Table 1.1) was added and incubated for 30 
minutes at 4°C. These cells were subsequently washed with FACS wash buffer, 
resuspended in 50pl FACS wash buffer and transferred to cluster tubes (Costar, 
Corning, NY). Single color standards and unstained controls were also prepared for 
compensation of the flow cytometer. Data was collected on a FACS (BD Bioscience, 
San Jose, CA) and analyzed with Flowjo software (Treestar San Carlos, CA). 
2.6.1 Antibodies used for Flow Cytometry 
The following is a list of antibodies used in various flow cytometry experiments. 
Primary antibodies are classified by their conjugation to FITC, APC, PE or PerCP. In 
the case of biotin conjugated antibodies, a secondary antibodies stain is required: 
streptavidin (SA) - conjugated to a fluorochrome. 
A l t ! gen Gbni ugati on • l u t i o n Vendor 
Hjran CM AHJ 1:50 G^TA3 1 aboratori es 
N A 7AAD 1:200 l\4)l ecu! ar pr obes 
Hjnan K I H bi ot i n 1:100 BD Fhar rtii ngen 
B oti n PE 1:2000 BD Fhar rti ngen 
2.7 Common buffers and chemicals 
2.7.1 Phosphate Buffer Saline (PBS, prepared by JCSMR media services) 
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i\ba 8 . 0 g/L 
• sodi umhydrogen ort hophosphat e 1 .25 g/L 
Sodi um di hydrogen ort hophosphat e (rnonohydrat e) 0 . 3 5 g/L 
2.7.2 Tris- acetate-EDTA (TAE) electrophoresis Buffer 
Tr i s - acet at e 40 rM 
bUIA 1 rri/i 
2.7.3 EtBr staining Buffer 
a Br (lOng/nL) Chi O) 200 \i 1 
ddKO 1 L 
2.7.4 FACS Wash buffer 
PBS 
Sodium Azide 0. 1% 
Fetal Calf Serum 2% 
2.7.5 Agarose Gel Loading Dye 
Bromophenol Blue 1 mg/ml 
Glycerol 20% 
2.7.6 5x Sequencing Buffer 
Tris-HCl 400 mM 
MgCU 10 mM 
pH 9 . 0 
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2.7.7 Ampicillin Agar Culture Plate 
LB b r o t h (JCSM^ n«di a) 
Bact 0 / ^ a r W v (Beet on • ckson, M)unt ai n Vi e\A< G^ 1.5% 
Aipi ci 11 i n (BDehr 1 nger, l^nnhei rr) I R ^ 100 p g/nli 
2.7.8 Hepes Buffered Saline (HBS) buffer 
HEPES (pH 7.4) 10 nVI 
NaCl 150 n y 
EDTA 3.4 rM 
Surfactant P20 (BIAcore) 0. 005% 
2.7.9 Luria-Bertani LB broth 
Tryptone \% 
Yeast extract 0.5% 
NbQ 1% 
2.8 Statistical Analysis 
Where appropriate, a two-tailed non-paired T test was performed where Gaussian 
distribution was not assumed (Mann-Whitney test). P-values denoting statistical 
significance were considered significant when less than 0.05 and marked with an 
asterisk (*). P-values considered extremely significant when less than 0.01 were marked 
with an asterisk (**). All statisticed analysis was performed using Excel (Microsoft) 
and Graphpad Prism (GraphPad Software, San Diego, CA). 
2.9 Bioinformatics tools 
For this study, bioinformatics tools used are listed below: 
P r i m e r 3 - designing PGR primers. Whitehead Institute for Biomedical 
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Research, (http://frodo.wi.mit.edu/cgi-
bin/pri mer3/pri mer3_w w w. c g i) 
B L A S T - searching sequence homology, NCBI. 
(http://www.ncbi.nlm.nih.gov) 
BLAST 2 Sequence - pair-wise alignment-based comparison of sequence, NCBI. 
(http://www.ncbi.nlm.nih.gov/) 
E N S E M B L - public mouse genome assembly. Mouse genome sequencing 
consortium, (http://www.ensembl.org) 
V I S T A - a comprehensive suite of programs and database for 
comparative analysis of genomic sequences, 
(http://genome.lbl.gov/vista/index.shtml) 
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§ THREE § 
Icos 3'UTR is required to mediate 
Roquin's repression 
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3. 1 Introduction 
In sanwque mice there is a striking overexpression of ICOS on CD4"^ T cells in both 
naive (CD44''"') and memory/activated populations compared to their wild-
type counterparts (Fig. 3.1 A) (Vinuesa et ai, 2005a). The aberrant expression of ICOS 
caused by the M199R mutation in Roquin is intrinsic to T cells: in 50%:50% mixed 
bone marrow chimera experiments only T cells derived from the saii/san, but not wild-
type bone marrow displayed high expression of ICOS. These data suggest Roquin acts 
in T cells to repress ICOS expression. 
When sanwque mice were crossed with TCR"' ' :insHEL double transgenic mice, 100% 
of san/san: TCR"''' :insHEL mice became diabetic by 3-7 weeks of age, and ~ 60% of 
5fln/+:TCR"''' mice also developed diabetes with slightly delayed onset. In these mice, 
diabetes was accompanied by very high titers of anti-HEL IgG autoantibodies and 
robust germinal-center reactions within the pancreas and draining lymph nodes, 
suggesting a profound failure to control T- cell help to self-reactive B cells in sanwque 
mice (Vinuesa et a\., 2005a). When gene expression was compared between purified 
san/san and +/+ CD4"^ T cells, there was a subset of genes that were more highly 
expressed in sanwque T cells. This included molecules important for successful T: B 
cell interactions in germinal centres, such as IL-21,IC0S, CXCR5 and CXCL13 
(Vinuesa et ai, 2005a) (Figure 3.1B). 
There is considerable evidence to suggest the ICOS: ICOSL pathway appears to be 
particularly important for the formation of germinal centers, the selection of memory B 
cells, and probably for the maintenance of self tolerance. Only recently, studies by Di 
Yu in our laboratory have confirmed a direct role for ICOS overexpression in the 
pathogenesis of the lupus syndrome in sanwque mice (Yu et ai, 2007). I then set out to 
investigate the mechanism by which Roquin regulates ICOS expression. We already 
knew that /cos mRNA levels were increased in sanwque mouse T cells (Figure 3. IB), 
thus it was unlikely that ICOS overexpression was due to post-translational regulation 
(i.e. ubiquitin-mediated degradation). Our starting question was whether this regulation 
was occurring at a transcriptional or post-transcriptional level. We had several important 
clues that together suggested Roquin might be involved in post-transcriptional 
regulation of Icos mRNA: 
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1) Roquin's CCCH type zinc finger motif has been unequivocally shown to directly 
bind to RNA sequences found in the 3'UTR of target genes (Hudson et al., 2004; 
Kashanchi and Brady, 2005). This alone suggests Roquin might be a RNA-binding 
protein. 
2) Roquin localizes to SGs. SGs are sites where mRNAs are sorted and stored in a 
translationally-inactive state, and many of them directed to processing bodies (PBs) 
for degradation (Anderson and Kedersha, 2006). Thus it is possible that Roquin acts 
on Icos mRNA to influence its stability or translation. 
3) Icos mRNA contains a very long 3' untranslated region (UTR), which is over three 
times the size of the coding sequence (CDS) and has six areas that are as highly 
conserved as the coding region with over 70% homology in 100 bps (Figure 3.2). 
Many regions, particularly those that are AU-rich, found in transcripts containing 
long 3'UTRs have been shown to contain regulatory elements for mRNA stability, 
translation and localization (Zhang et al., 2007). 
4) Co-transfection of HEK 293T cells with a construct expressing Roquin and another 
construct expressing ICOS either in its full length form {hulcos^ ^'), or lacking the 
3'UTR {hulcos''^^) showed Roquin repressed ICOS expression only when Icos 
mRNA contained the 3'UTR (Figure 3.3) (Yu et al, 2007). Unfortunately these 
results were not very consistent and were hard to quantify, partly due to using 
transfection into HEK293T cells (see below). 
In the first part of this chapter, I will describe a new method I set up with the help of Di 
Yu to perform these regulatory studies- a retrovirus-mediated system of NIH3T3 cell 
transduction. In the rest of this chapter and subsequent two chapters, I have applied this 
system to identify the cw-acting elements in two different Roquin target genes, Icos and 
Tnf. 
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A C D 4 4 0 * 
B 
Trusl 
F igure 3.1 
A. ICOS expression on naive (CD44' and activated/ memory (€044' ' '^") CD4' ' T cells f rom 
stmroque mice {san/san, open histogram) and f rom wild-type mice (+/+, shaded histogram). 
B . Expression of Ti H-associated genes in purified CD4 splenic T cells f rom 12-weeks old 
sati/san mice compared with +/+ littermates using Affimetrix microarrays. Two replicas are 
shown. 
Reproduced from: Viniiesa, C.G. et al. Nature 435,452-8(2005). 
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Species RefSeq jlengthf CDS jlength! 
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Figure 3.2 ICOS mRNA has highly conserved regions within 3'UTR 
A. The indicated human and mouse ICOS full length nucleocide sequence (cDNA) were 
chosen from the GenBank database. 
B. Human and mouse Icos nucleocide sequence were aligned using LAGAN (VISTA server 
http://genome .lbl.gov). Areas filled in pink represent conserved regions with more than 
70% homology across 100 bps. 
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Figure 3.3 HEK293T cells transfection system to evaluate Roquin's repression of ICOS 
expression. 
Flow cytometric analysis of H E K 2 9 3 T cells transfected with two constructs: 
1) Roquin or empty vector - tagged with G F P 
2) hu Icos FL or hu Icos A3' UTR 
Each combinat ion is shown above as a separate dot-plot. 
Contour- plot show G F P vs huIcos expression on each HEK293T cell population. 
Repression of hulcos by Roquin was only observed when hu lCOS was expressed f rom full length 
hitlcos ihulcos^'^ ) vector and is indicated with an arrow. 
Di Yit performed these preliminary experiments using HEK293T cells 
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Figure 3.4 Disadvantages of using HEK293T cell transfection 
A. Schematic diagram of the vectors used to transfect Icos and Roquin into HEK293T cells. 
B. Flow cytometric analysis of HEK203T cells singly transfected with the pR-Roquin-IRES-GFP 
vector. Contour plot showing the fluorescence deteced in FLl and F12 channels. There are cells 
expressing GFP with a fluorescent tensity over 1,000 units, leaking into FL2 channel (arrow). 
C. Histograms show mean flurescent intensity (MFI) of GFP in HEK203T cells transfected with the 
pR-Roquin-IRES-GFP vector, with different efficiency. Left experiment in which there is low 
transfection efficiency. Right experiment in which there is high trasfection effiency. 
D. Contour plots of single or double transfected HEK293 with the vectors indicated (labels on top) 
showing GFP vs huCD4 fluorescence. 
Di Yu perfonned these preliminary experiments using HEK293T cells 
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3.2 Development of a retrovirus-mediated transduction system to 
investigate the regulation of target mRNA by Roquin 
When HEK293T cells were co-transfected with the constructs shown in Figure 3.4 to 
investigate Roquin's repression of ICOS, a few important problems were observed: 
1. A fraction of the cells are highly transfected and express excessively high levels of 
reporter protein (GFP) resulting in fluorescent interference (i.e. FLl fluorescence 
leaking into FL-2, Figure 3.4B). 
2. Varying transfection efficiencies with different constructs makes it difficult to 
quantify gene-dose dependent effects (Figure 3.4C). 
3. High correlation between the efficiency of transfection between two constructs 
makes interpretation of the data very difficult (Figure 3.4D). For our experiments it 
is very useful to have control cell populations expressing high amounts of one 
construct and low (or ideally nil) amounts of the other construct. This was never 
observed in experiments using HEK293T cell transfection. 
For all of the above reasons we decided to establish a retrovirus-mediated gene 
transduction system into NIH3T3 cells. This system has the following advantages: 
1. The transduction efficiency correlates very well with the concentration of 
retroviral particles present in the supernatant (Figure 3.5A). 
2. The relationship between transduction efficiency and amount of retroviral 
supernatant can be calculated using a trend line fitted to the experimental data 
(Figure 3.5B). 
3. This allows virus titration, and calculation of the optimal concentration that 
leads to comparable and constant transduction efficiencies across the different 
constructs (Figure 3.5C). 
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Figure 3.5 Explanation of the method used to titrate retrovirus -containing 
supernatant 
A. Flow cytometry analysis of NIH3T3 cells transduced with the indicated 
volumes of a retrovirus-containing supernatant. Histograms indicate GFP 
fluorescence of transduced cells. The percentages of GFP positive cells shown 
are an indicator of transduction efficiency. 
B. Dot plots showing the amounts of retrovirus-containing supernatant in a 
logarithmic scale (Y-axis) vs the percentage of transduced cells in a linear scale 
(X-axis). Trend lines were added to estimate viral titres. Left: Retrovirus 
expressing Roquin^^; right: retrovirus expressing 
C. The equation predicted by each trend line is used to calculate the amount of 
retrovirus-containing supernatant required to achieve 50% transduction 
efficiency. 
D. Flow cytometric analysis of NIH3T3 cells transduced with the amounts of 
retrovirus-containing supernatant. Dot blots show the % of GFP"^ cells after one 
transduction; each symbol represents a separate population of transduced cells 
(transduced separately). Lines are drawn through the median values for each 
group. The transduction efficiencies of N1H3T3 cells transduced with 
Roquin^^-(left) and Roquin'^'^'^'^-(right) expressing retroviruses were compared 
in parallel. 
This NIH3T3 system was developed under the guidance of Di Yu. 
My contribution to these experiments is estimated to be~80%. 
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3.3 The 3'UTR, but not the coding region within Icos mRNA is 
required for Roquin's regulation 
I set out to confirm the finding that the repression of ICOS expression by Roquin 
requires 3'UTR of Icos mRNA using retrovirus-mediated transduction of NIH3T3 cells. 
I generated the following constructs (Figure 3. 6): 
• hulco/'^: huICOS full length cDNA, subcloned into the multiple cloning site 
upstream of the IRES in the retroviral vector pR-IRES-huCD4 
• hulcos^'^^ huICOS cDNA lacking the 3'UTR and 5'UTR. subcloned into the 
multiple cloning site upstream of the IRES in the retroviral vector pR-IRES-
huCD4. 
• Roquin^^ cDNA mouse sequence was subcloned into the multiple cloning site 
upstream of the IRES in the retroviral vector pR-IRES-GFR 
• Roquin'^'^^'^ cDNA mouse sequence was subcloned into the multiple cloning 
site upstream of the IRES in the retroviral vector pR-IRES-GFR 
A retroviral supernatant from each individual retroviral construct was harvested from 
Phoenix cell cultures (the packaging cell line) and titrated to achieve about 50%-60% 
transduction for each retrovirus under the same conditions (spinoculation at 30"C and 
2500rpm for 90minutes). NIH3T3 cells were co-transduced with supernantants from 
these constructs in the following combinations (Figure 3.7A) 
1. Either pR-/?o^Mm"^-IRES-GFP or pR- or empty pR- IRES-
GFP vector (also referred to as empty*^"^^" '^' '') 
Plus 
2. pR-/zM/ro/^-lRES-huCD4 or pR- hulcos^'^^ -IRES -huCD4. 
In these constructs, hidcos mRNA fragments were subcloned into the retroviral vector 
pR-IRES-huCD4, upstream of an internal ribosomal entry site (IRES) in the bicistronic 
message of hulcos cDNA. Thus, huCd4 and Icos cDNAs are transcribed into a single 
transcript, although translation occurs independently. That means the huCD4 maker 
gene may also serve as a reporter maker for ICOS expression, if Roquin exerts its 
repression on the transcript (i.e. regulating mRNA abundance rather than translation). 
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Figure 3.6 Schematic representation of the retroviral constructs. 
A. The full length (FL) or coding sequence (CDS) of hulcos cDNA were inserted 
into the retroviral vector pR-IRES-huCD4 using the restriction enzymes Bgl II 
and Xhol I. The number indicates the base pair position within the BC028210 
sequence. 
(1) pR-huIcos" - IRES-huCD4 
(2) pR-huIcos^""^- IRES-huCD4 
B. Wild-type (Roquin^^) and mutant (Roquin'^'^^'"') Roquin cDNA were inserted 
into the retroviral vector pR-IRES-GFP using the restriction enzyme EcoR I. 
(1) pR-Roquin^^-IRES-GFP 
(2) pR-Roquin^''^^'^-IRES-GFP 
(3) pR-IRES-GFP (empty vector control, also referred to as Empty"^"^^"""') 
41 
Fig. 3.7 
A 
5'LTR 
huiCOff''-
hulCOS^ 
- c p : ^ 
3'LTR 
TIzZZZZZH 
5'LTR 
IRES hiiCD4 
IRES GFP 3'LTR 
5553C 
hulCOSf^ L retrovirus 
hulCOSCDs retrovirjs 
Roquin^^ retrovirus 
Roquln'"^ ®®'' retrovirus 
Roquin'^ 
B 
Roquirf^^^ 
hulCOST'-
^ Emptv'^'^v.GFP retrovirus (control ) 
Co-transducing NIHr3T3 
cells 
E m p t / ' ^ ^ f P 
RoquinWT 
Single t ransduct ion 
Q. Ll. 
ts 
FACS 
I 
FACS 
I 
Single transduction Single transduction 
pR-Roquin^ pR-hulCOS'^^^ 
- IRES-GFP -IRES-huCD4 
FACS 
i 
Double transduction 
pR-Roqu/ f i '^ - IRES-GFP 
pR-ft w/GOSCOs. IRES-I-IUCD4 
huCD4 
42 
Figure 3.7 Flow chart summarises the experiment plan for the retrovirus-mediated 
gene transduction of NIH3T3 cells 
A. Retroviruses packaged from the constructs shown in Fig. 3.6. 
B. After titration, the selected amount of retrovirus was used to transduce cells 
seeded in the 24-well plates. The different combinations of the retroviruses that 
were used for transduction are shown. Double transduction experiments were 
always performed in triplicate and then repeated in a separate experiment. Single 
transductions were performed in order to calibrate the flow cytometer and 
establish the compensation settings. 
C. Representative flow cytometry contour plots showing singly transduced and 
doubly transduced cells. 
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Two days after transduction, NIH3T3 cells were analyzed by flow cytometry (Figure 3. 
7B/C). The gating strategy used for this analysis is shown in Figure 3.8 and 3.9. 
1. A live cell gate was first placed according to size (forward scatter) and granularity 
(side scatter) (Figure 3.8A). 
2. Dead cells were excluded from analysis by gating only cells that were 7AAD'"* 
(Figure 3.8B). 
3. GFP versus ICOS fluorescence was plotted to observe the effect of Roquin on 
ICOS expression since Roquin was expressed from a bicistronic vector also 
expressing GFP (Figure 3.8C). 
4. Cells were divided into three populations: Roquin"' (GFP"'), Roqu in ' (GFP ' - " ' ' ) 
and Roquin"^'' (GFP^"), according to the level of GFP expression (Figure. 3.9A). 
The method used to quantify Roquin-mediated repression of ICOS is explained in 
figure 3.9B. 
After performing the analysis described above, I quantified the level of ICOS repression 
by the different Roquin vectors expressing ICOS expression levels as the percentage of 
the level seen in cells transduced with the empty pR-IRES-GFP construct. 
Roquin^^ exerted a potently inhibitory effect on hulCOS expression when cells were 
co-transduced with the hidCOS^^ construct, containing the 3'UTR. Indeed, a high dose 
of Roquin^^ repressed huCD4 expression to 45% and repressed huICOS expression to 
25% of the levels found in cells transduced with the empty-GFP vector. A comparable 
dose of Roquin'^''^'^'^ repressed huCD4 expression to 60% and huICOS expression to 
45%. A low dose of Roquin^^ repressed huCD4 expression to 75% and huICOS 
expression to 70%, while Roquin"^"^ '^^  repressed huCD4 expression to 80% and huICOS 
expression to 90%. In cells lacking Roquin expression, there was no significant 
repression of huCD4 or of huICOS (Figure 3.10). These results show that the cells with 
highest GFP expression - indicating a higher gene dose of Roquin - exert a more potent 
repressive effect compared to cells with low levels of Roquin expression. This is an 
important result that indicates Roquin represses ICOS expression in a gene-dose 
dependent manner. Moreover, as predicted, the Roquin" '^^ ^*^ mutation was less capable 
of repressing huCD4 and huICOS expression, which confirms this mutation diminishes 
but dose not abolish Roquin's function. 
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Roquin^^ could not down-regulate ICOS expression when cells were co-transduced 
with hulCOS CDS lacking huIC0S3 'UTR (figure 3.10). This result confirmed Di Yu;s 
previous finding using the HEK293T cells system, of Roquin repressing ICOS 
expression through its 3 'UTR. 
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Figure 3.8 Gating strategies for the flow cytometric analysis. 
A. Region one (R1) was placed based on size (forward scatter) and granularity (side 
scatter) to gate live cells and eliminate dead cells and/or debris. 
B. R2 was placed on the cell population gated in Rl , to exclude dead cells that are 
7AAD positive. 
C. Cells from R2 were plotted as contour plots showing GFP versus huCD4 (or 
ICOS where indicated). 
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Figure 3.9 Quantification of Roquin-mediated repression. 
A. Retroviral litres were determined to consistently achieve a transduction 
efficiency of 50-60% of NIH3T3 cells. Upper panel: cells transduced with 
Roquin-expressing retroviruses. Lower panel: cells transduced with empty 
vector. For cells transduced with Roquin (thus GFP"^), the half with higher GPP 
expression was defined as the Roquin"* population (Gate 1), while the half with 
lower GPP expression was defined as Roquin''""' population (Gate 2). Cells that 
were not transduced are shown in gate 3 (these cells are referred to in the text as 
Roquin'^'VGFP'^''). Similar gates were placed in the empty-vector transduced 
cells (gate 4, 5, 6). The MPI of ICOS in each population is shown. 
B. The MPI of ICOS in populations with different levels of Roquin transduction 
was normalized to the counterpart population from cells transduced with empty 
vector (pR-lRES-GPP). 
This method of quantification using the retrovirus-mediated gene transduction cell 
system was developed by Di Yu. 
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3.4 Summary 
In this chapter, we developed a retrovirus-mediated NIH3T3 cell system to investigate 
the regulation of ICOS expression by Roquin. This system allows quantification due to 
the possibility to control for transduction efficiency of the different constructs. 
The experiment performed shows ICOS expression is most potently repressed in those 
cells that are transduced with the highest levels of exogenous Roquin. indicating 
repression occurs in a Roquin dose-dependent manner. The same Roquin dose-
dependent repression was also observed for huCD4 expression. 
Importantly. mRNA repression was only observed when ICOS was expressed from 
transcripts containing the 3'UTR, indicating this region contains m-acting element(s) 
critical for Roquin-mediated regulation. 
Finally, Roquin'^ '^'^ '^^  was unable to repress either ICOS or huCD4 expression to the 
levels seen with Roquin^^^, but did exen some inhibitory effect adding further evidence 
to the suggestion this is a hypomorph rather than a null allele. 
Together these results show Icos mRNA 3'UTR is required for the repression of ICOS 
expression by Roquin and impaired 3'UTR-mediated repression might be the cause of 
ICOS overexpression on sanroque CD4"^ T cells. 
49 
Fig. 3.10 
2.O. 
« ^ 1.5. O T3 
0 ® N 
1 ? 1.O. 
"fe £ 
f o u. c ^ — O.5. 
o.o. 
ICOSFL 
• 
m 
I 1 A 
r^X 
cD 
Hi Low None 
ICOSCDS 
Hi Low None 
B 
1.5-
ICOSFL -
Q "O H n 
^ S 
I 
O 1 
E ? 0.5-
0.0-
Hi Low None 
ICOSCDS 
X 
Hi Low None 
I 1 roquin^T 
roquinMi99R 
50 
Figure 3.10 Repression of ICOS expression by Roquin requires 3'UTR in ICOS 
m R N A . 
A. NIH3T3 cells were transduced with two retroviruses: one expressing either 
hulcos^^' or the other expressing Roquin'^^, Roquin* '^^ ^*^ or empty 
vector as indicated. The repression of hulcos expression by either Roquin^^ or 
Roquin'^'^^'^ was quantified using the method descried in Fig 3.11. The bars 
show the normalized MFI of huICOS in cells with different levels of Roquin^^ 
(open bars) or Roquin"^'^^'^ (filled bars) expression. 
B. In this experiment huCD4 MFI is measured since huCD4 is downstream of 
hulcos in the bicistronic vector (see Fig 3.6a). The repression of huCD4 
expression by either Roquin^^ or Roquin'^'^^'^ was quantified using the method 
described in Fig 3.9. Open bars represent cells expressing Roquin*^ and filled 
bars represent cells expressing Roquin'^'^^'\ 
Data shown represent mean value ±S.D with n=3. Student's test *P<0.05; **P<0.01. 
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§ FOUR § 
The distal fragment within Icos 
3'UTR contains the c/5-acting 
element(s) and promotes Roquin 
mediated Icos mRNA decay. 
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4.1 Introduction 
The results provided in the previous chapter have shown that the long 3'UTR of Icos 
mRNA is the regulatory region that mediates Roquin's repression. We next set out to try 
and identify which are the responsible cw-acting element(s) within Icos mRNA 3'UTR. 
Different c/'s-acting elements have been shown to regulate mRNA through different 
mechanisms; typically, AU-rich elements (ARE) mediate mRNA decay (Gingerich et ciL, 
2004), while for example micro-RNA (miRNA) target sequences predominantly 
regulate translation (Bartel, 2004). It then emerges that identification of regulatory 
elements may provide important information as to Roquin's mechanism of regulation. 
In most cases, r/5-acting element(s) for mRNA regulation are no longer than 100 bp and 
can be predicted by bioinformatic analysis that identifies sequence patterns (Pesole er 
al., 2002). The unusual length of the 3'UTR of hulcos mRNA - over 2kb long - greatly 
increases the possibility of false positive results using this approach. We decided to first 
identify a smaller region of hulcos 3'UTR responsible for the repressive effect, and only 
then use bioinformatic tools to predict the regulatory element(s). 
Due to their physiological role in regulating gene expression, m-acting elements in 
untranslated sequence tend to maintain their critical sequence patterns through evolution. 
Therefore, they are often in the core of the conserved regions across species. By 
performing a BLAST alignment between human and mouse Icos 3'UTR, we could 
identify six highly conserved regions (Figure 3.2). We then divided the 3'UTR into 
three fragments, with the criteria that they should be roughly of comparable size; each 
of them should contain one or more such conserved regions; and the boundaries 
between each fragment should not interrupt any conserved sequence (Figure 4.1 A). 
• Fragment one (Fl) comprises conserved regions • 2 and • 3, with a 
length of 713 bp (from 635 to 1348, BC028210); 
• Fragment two (F2) comprises conserved regionD 4, with a length of 535 
bp (from 1349 to 1884, BC028210); 
• Fragment three (F3) comprises conserved regionsD 5, • 6 and • 7, with a 
length of 766 bp (from 1885 to 2651, BC28210). 
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Figure 4.1 Schematic representation of the retroviral constructs. 
A. The following hulcos fragments were inserted into the retroviral vector pR-
IRES-huCD4 using the restriction enzymes Bg II and Xho I or AF3+F2, lacking 
F3+F2 hulcos cDNAs were. 
(1) pR-/zM/co/'--IRES-huCD4: Full length (FL) hulcos cDNA 
(2) pR-/iM/co5^' -^-IRES-huCD4: hulcos cDNA lacking F3 
(3) pR-/?M/co5^''^^^^-IRES-huCD4: hulcos cDNA lacking F2 and F3 
B. Wild-type (Roquin^^) and mutant (Roquin'^''^^'^) Roquin cDNAs were 
inserted into the retroviral pR-IRES-GFP vector using the restriction enzyme 
EcoR I. 
(1) pR-Roquin^^-IRES-GFP 
(2) pR-Roquin^''^'^'^-IRES-GFP 
(3) pR-IRES-GFP 
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4.2 F3 within 3'UTR is required for the repression of ICOS by Roquin 
In order to test the requirement of each fragment for the repression of ICOS expression 
by Roquin, truncated forms of hulcos mRNA were constructed and subcloned into the 
retroviral vector pR-IRES-huCD4 used in the previous studies: 
• hulcos^''^: hulcos full length cDNA lacking the most distal fragment, F3, 
subcloned into the multiple cloning site upstream of the IRES in the 
retroviral vector pR-IRES-huCD4. 
• hulcos^^^''^. hulcos full length cDNA lacking both F2 and F3, subcloned 
into the multiple cloning site upstream of the IRES in the retroviral vector 
pR-IRES-huCD4. 
I then co-transduced NIH3T3 cells with retrovirus-containing supernatants from: 
1. pR-Roquin^^-IRES-GFP or pR-Roquin^''^'"^-lRES-GFP or pR-IRES-GFP 
empty vector; 
Plus 
2. pR-/iw/m/^-IRES-huCD4 or pR-huIcos^-\RES-huCD4 or pR-huIcos^''^^''^-
IRES-huCD4 or pR-/zM/co5^^^-IRES-huCD4. 
In this double co-transduction, expression of ICOS could be assessed by measuring 
surface huICOS or huCD4 protein levels, and expression of Roquin could be assessed 
by GFP expression, using flow cytometry. 
As shown in the previous chapter, both ICOS and huCD4 expression from hulcos'"'' 
were potently repressed by Roquin^^ (Figure 3.10). By contrast, these levels of 
repression were not observed when ICOS and huCD4 were expressed from hulcos^^, 
hulcos^''^*''^ or hulcos'^'^^ although a subtle repression was still observed when ICOS 
was expressed from hulcos^''^. Notably, when both F3 and F2 were absent from the Icos 
cDNA {hulcos^^'^''^), no repression could be observed (Figure 4.2). 
We also confirmed this repression was Roquin gene-dose dependent. Repression of both 
huCD4 and huICOS in cells transduced with / C 0 5 " retrovirus was about 2-3 times 
higher in cells expressing high levels of Roquin (GFP"') than in cells with low Roquin 
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Figure 4.2 Repression of ICOS expression by Roquin requires the F3 fragment 
with Icos mRNA. 
A. NIH3T3 cells were transduced with two retroviruses: one expressing ICOS from 
hulcos^'^' or hulcos^^^ or hulcos^^^*^^, the other expressing either Roquin^^ or 
Roquin'^'®'^'^ HuICOS expression was quantified using the method described in 
previous chapter. 
B. Same experiment as A, but here, instead of ICOS, HuCD4 expression from the 
same bicistronic vector was measured. The repression of huCD4 expression by 
either Roquin^^ or Roquin'^'^'''^ was quantified using the method described in 
previous chapter. 
Open bars represent Roquin^^ and filled bars represent R o q u i n " ^ D a t a shown 
represent mean values ±S.D. with n=3. Student's test *P<0.05; **P<0.01. 
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levels (GFP'") (P<0.01 in huICOS; p<0.05 in huCD4) (Figure 4.2). By contrast, there 
were no differences between GFP"', GFP '" and GFP^"' populations amongst cells 
transduced with ICOS° or ICOS"*"^ (Figure 4.2) 
All these results show that huIcos-3'UTR-F3 is required for the repression of ICOS 
expression by Roquin. The logical next question is whether this F3 fragment is not only 
necessary but is also sufficient for this repression. Two possible scenarios are that i) F3 
alone contains all the m-ac t ing regulatory element(s) or ii) F3 needs to interact with 
another element within a different 3 'UTR fragment to mediate this repression. 
4.3 F3 within 3'UTR is sufficient for the repression of ICOS by Roquin 
In order to test whether F3 in huIcos mRNA 3'UTR is sufficient to mediate Roquin's 
repression, the effects of F l , F2 and F3 were tested separately. Since all previous 
experiments have proved that the expression of huCD4 is a good reporter for evaluating 
the repressive effect, the three 3'UTR fragments were individually subcloned into the 
pR-IRES-huCD4 retroviral vector (Figure 4.3A). 
Next, NIH3T3 cells were co-transduced with supernatants from: 
1. Either pR-Roquin^^-IRES-GFP or pR-Roquin^''''^'^-IRES-GFP or pR-lRES-
GFP empty vector; 
plus 
2. Either pR-/zH/ro5^'-IRES-huCD4 or pR-/zM/co5^^-lRES-huCI)4 or pR-Aw/m/"^-
IRES-huCD4. 
When we compared the repressive effects exerted by F l , F2 or F3, it became obvious 
that F3 alone could mediate all the suppressive effect (Figure 4.4). No repression of 
huCD4 expression could be observed in cells transduced with either Icos-3'UTR-FI or 
Icos-3'UTR-F2-txprc&smg retroviruses (Figure 4.4). 
The data above clearly show that F3 within hulcos mRNA 3'UTR is necessary and 
sufficient to mediate Roquin's repression. Importantly, the repression exerted by Icos-
3'UTR-F3 is comparable in potency to the repression exerted by the entire 3 'UTR. This 
strongly suggests cw-acting elment(s) are localised within Icos-3'UTR-F3. 
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Figure 4.3 Schematic representation of retroviral constructs. 
A. F3, F2 or F1 hulcos cDNA were inserted into the retroviral vector PR-IRES-
huCD4 using the restriction enzymes Bglll and Xhol. 
(A)pR-hu/co/^-lRES-huCD4 
(B) pR-hu/co/^-lRES-huCD4 
(C)pR-hu/co/ '-IRES-huCD4 
B. Wild-type (WT) and M199R mutant Roquin cDNA were inserted into the 
retroviral vector pR-IRES-GFP using the restriction enzyme EcoR 1 
(D) pR-Roquin^^-lRES-GFP 
(E) pR-Roquin^''^^'^-IRES-GFP 
(F) pR -IRES-GFP 
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Figure 4.4 F3 within Icos 3'UTR is sufficient for Roquin's repression . 
NIH3T3 cells were transduced with two retroviruses: one expressing ICOS from 
hu/cos'^ or hu /co /^ or hu/co^' '; the other expressing either Roquin^^ or Roquin'^''^'"^ 
or empty vector. The repression of huICOS expression by either Roquin^^ or 
Roquin'^'^^'^ was quantified in cells expressing high, low or null levels of Roquin (GFP). 
Open bars represent Rqouin^^ and filled bars represent Roquin* '^^ ^*^. Data shown 
represent mean values ±S.D. with n=3. Student's test *P<0.05; **P<0.01 
62 
4.4 F3 within Icos mRNA 3'UTR mediates Roquin's promotion of 
mRNA degradation 
Messenger RNA 3'UTR-mediated repression of gene expression has been shown to 
occur through either i) enhancement of mRNA decay/instabihty (Conne et ai, 2000) or 
ii) inhibition of translation (Conne et al, 2000). We then decided to investigate which of 
these two processes was responsible for Roquin's repressive effect on ICOS expression. 
If Roquin destabilises Icos mRNA acting on Icos-3'UTR-F3, in cells co-transduced with 
Roquin, transcripts containing this F3 fragment plus huCD4 mRNA should be less 
abundant than transcripts containing the non-regulating F2 and F1 fragments. In order to 
test this, NIH3T3 cells were co-transduced with supematants from pR-Roquin^^^-IRES-
GFP plus either pR-/jM/ro/ ' -IRES-huCD4 or pR-huIcos"- IRES-huCD4. 
Two populations were separately sorted: 
i) Cells highly transduced with Roquin (GFP"') 
ii) Cells not transduced with Roquin (GFP^'') 
HuCcl4 mRNA abundance was quantified by quantitative real-time RT PCR. The effect 
of each fragment (F1 or F3) on mRNA degradation can be determined by comparing 
mRNA abundance between Roquin"' and Roquin"^'' populations in cells transduced with 
lcos-3'LJTR-Fl-huCd4 or cells transduced with Icos-3'UTR-F3- huCd4. 
When huCd4 mRNA was tagged with Icos-3'UTR-Fl, there was no regulation of 
huCD4 expression regardless of the dose of Roquin (GFP) expression (Figure 4.4). 
However, in experiments where huCd4 mRNA was tagged with Icos-3'UTR-F3, those 
cells with high levels of Roquin expression had more than a 3-fold decrease in huCd4 
mRNA transcripts compared to cells without exogenous Roquin expression (Figure 4.4). 
This can be seen in the figure as a repression of huCd4 mRNA levels to 70-80% of the 
levels seen in cells lacking exogenous expression of Roquin (Figure 4.5B). 
The results above show Roquin exerts a potent effect on ICOS mRNA decay acting 
through Icos-3'UTR-F3. The question remaining is whether all of Roquin's repressive 
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Figure 4.5 Roquin represses mRNA abundance through the F3 fragment within 
Icos 3'UTR 
A. Gating strategy used to exclude cellular debris and cell conjugates for sorting. 
B. NIH3T3 cells were trasduced with two retroviruses: one expressing ICOS from 
either hulcos^^ or hulcos^'^, the other expressing Roquin*^. Two cell populations 
were sorted separately: one cell population expressing high level of Roquin 
(QPpHigh^. jj^ g ^jj^gj. ^gjj population lacking Roquin expression (GFP^''). The 
purity of the sorted cells was measured. Total RNA was isolated and quantitative 
RT-PCR was performed to measure HuCD4 mRNA levels, which were 
normalized to P-actin. The bar graph shows relative huCD4 mRNA in GFP"'®^ 
cells compared to GFP'^"- cells (GFP"7GFP^" ratio). 
The filled bar represents hu/cos" and the open bar represents hu/cos'^. Data 
shown represent mean values ±S.D. with n=4 different primer pairs designed to 
amplify different fragments of huCD4 cDNA. 
This experiment was preformed by DI Yu and Xin Hu. 
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effect acts through the control of mRNA decay, or some effect might be attributed to 
Roquin's action on translation of mRNA. Since Roquin's repression of huCD4 (protein) 
expression is reduced to 70%-80% of the levels seen in empty vector controls (figure 
4.4), and this exactly corresponds to the levels of repression of target mRNA levels 
described above, it is likely that of Roquin's repressive effect acts at the level of 
regulation of mRNA abundance (see also below for further evidence showing Roquin 
regulates mRNA decay). 
4.5 SUMMARY 
The results in this chapter have demonstrated that the most distal fragment within Icos 
3'UTR mRNA - Icos-3'UTR-F3- is both necessary and sufficient to mediate ICOS 
repression by Roquin. We have shown further evidence that Roquin represses ICOS 
expression in a dose-dependent manner. Importantly, and as shown in the previous 
chapter Roquin^ '^*^ '^^  is a less efficient repressor of huICOS and huCD4 expression 
irrespective of the level of Roquin expression, suggesting once again that the sanroque 
mutation reduces but does not abolish this repressive activity of Roquin. Finally, I have 
provided evidence that Roquin's effects are likely to regulate mRNA abundance as 
opposed to regulation of translation. 
Subsequent to my experiments described above identifying the region of Icos 3 'UTR 
important for Roquin's repressive effect, and pin-pointing the latter as an effect of 
mRNA stability, Di Yu, a PhD student in the lab performed in silica analysis of this F3 
region within ICOS 3'UTR, and identified the existence of five miRNA-binding sites 
within this stretch of RNA. Importantly, this mRNA segment lacked typical AU-rich 
elements. Di Yu and I together, subcloned the three minimal 47bp regions; two of them 
containing the microRNA-binding sites and discovered only one of these minimal 47bp 
regions could mediate ICOS repression by Roquin. Intriguingly, this region alone 
contained four of the five miRNA-binding sites, and one of these, hsa iniR-IOI, has 
been found to be expressed in both NIH3T3 cells and mouse T cells. When Di Yu 
inverted two nucleotides of ICOS 3'UTR mRNA complementary to seed sequence of 
this miRNA predicted to abolish binding of the miRNA, the repressive activity was 
severely impaired. This suggests ICOS repression by Roquin might involve the miRNA 
machinery (Yu et ciL, 2001). 
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In parallel, our collaborators Andy Hee-Meng Tan and Kong Peng Lam confirmed 
Roquin's effect on Icos mRNA abundance was in fact due to increasing mRNA decay. 
This was performed activating mouse EL4 cells before transfection with Roquin 
followed by treatment with Actinomycin D (ActD) to block transcription. They showed 
that in ActD-treated cells, Roquin overexpression shortened Icos mRNA half-life by 
half compared to empty vector. 
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§ F I V E § 
TNF is also a target for post-
transcriptional regulation by Roquin 
68 
5. 1 Introduction 
The chronic course of most autoimmune diseases including autoimmune arthritis, 
Systemic Lupus Erythematosus and inflammatory bowel disease, has been shown to at 
least in part be the consequence of a sustained inflammatory process due to the inability 
to turn off pro-inflammatory signals - including cytokines - produced by innate immune 
cells (Nathan, 2002). Amongst innate cells of the immune system, macrophages, 
neutrophils and mast cells play prominent roles in many inflammatory conditions. 
Multiple signals are capable of inducing macrophage activation either by surface 
receptor ligation, as is the case of ligands for Toll-like receptors (TLR) and 
immunoglobulins that bind Fc receptors, or simply by crossing the cellular membrane as 
is the case of nitric oxide (NO) and PMA (Han and Ulevitch, 2005; Mandik-Nayak and 
Allen, 2005). Regardless of the stimuli, macrophage stimulation results in the 
generation of downstream signals that converge to promote transcription exerted by 
N F K B and MARK pathways, resuhing in changes in gene expression (Han and Ulevitch, 
2005). TNF is one of the key target genes of NFKB and an important mediator of pro-
inflammary responses. 
TNF is a cytokine involved in systemic inflammation and causes apoptotic cell death, 
cellular proliferation, and cell differentiation (Locksley et al., 2001). TNF also plays a 
role in immune regulation and lymphoid organogenesis (Douni et ai, 1995; Pfeffer, 
2003). Recent studies have identified a role for TNF in several autoimmune diseases in 
humans and mouse models including lupus, autoimmune diabetes and autoimmune 
arthritis (Chamberlain et ai, 2006; Conway et ai, 2001; Kassiotis and Kollias, 2001; 
Nash and Florin, 2005). Anti-TNF therapy has also shown dramatic success in the 
symptomatic treatment of patients with rheumatoid arthritis. 
Sanroque mice have high levels of serum TNF compared to littermate controls (D. Silva 
personal communication). In a model of arthritis induced by transfer of K/BxN 
arthritogenic serum into lymphocyte-deficient RAGl-/- mice, arthritis is more severe 
when the recipient mice are homozygous for the sanroque mutation (D. Silva et al., 
manuscript in preparation). The cytokines IL- ip and TNF have been shown to be 
important effectors of the antibody-mediated arthritis of K/BxN mice (Ji et al., 2002). 
Increased severity of arthritis in sanroque RAGl-/- mice has been shown to be 
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associated with increased amounts of TNF produced by sanroque macrophages 
compared to controls. When the levels of Tnf mRNA were assessed by real time PCR, 
sanroque macrophages were shown to have higher levels of Tnf mRNA compared to 
Roquin+/+ macrophages (D. Silva personal communication). 
TNF expression is not only regulated at the transcriptional level, but there is also solid 
evidence that it is also post-transcriptionally regulated. TNF induces the expression of 
tristetraprolin (TTP), which in turn destabilizes and degrades Tnf mRNA. Importantly, 
TTP knockout (KO) mice develop a systemic inflammatory syndrome with severe 
polyarthritis and autoimmunity, as well as medullary and extramedullary myeloid 
hyperplasia (Carballo et ai, 1998; Carrick et ai, 2004; Taylor et ciL, 1996). TTP"^" 
macrophages, derived from fetal liver, bone marrow and peritoneal cavity, released 
more TNF than macrophages from their TTP ^^ littermates (Carballo et ai, 1998). All 
of these phenotypes were associated with an increase in the stability of TNF in the KO 
cells. In experiments blocking TNF transcription with Actinomycin D, in the absence of 
TTP there was an increase in the half-life of TNF, implying a decrease in Tnf mRNA 
turnover rate (Blackshear, 2002). The molecular mechanism of the regulation exerted by 
TTP has been elucidated: TTP, which contains two tandem CCCH domains - nearly 
identical to Roquin's single CCCH domain, directly binds a highly rich AU-rich region 
within TnfS'ilTR mRNA (Fig. 5.1) and in doing so enhances deadenylation which leads 
to mRNA decay (Carballo et ai, 1998). 
If we combine the evidence that there is dysregulation of TNF expression in sanroque 
mice demonstrated by very high 7/z/mRNA levels and serum TNF, together with our 
knowledge of Roquin regulating other targets (Icos) at the mRNA level in stress 
granules, and the data showing TNF is strongly regulated at the level of mRNA stability, 
we can put forward the hypothesis that Roquin participates in TNF's post-transcriptional 
regulation. We then set out to test whether Roquin's putative role in TNF's regulation 
acts on r n / 3 ' U T R . 
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rCCCTCAGCAACGACAGCAGAGGACCAGCTAAGAGO&AtiAaAA&CAACTACAGACCCCI 
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121 CTC AC ATACT GACC C ACCG CTCCA CCCTCTCTCC CCTGC AAAGG AC AC C|A7CAG CACT CA 
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361 CAGGGACCTCTCTCTAATCAGCCCTCTGGCCCAGGCAGTCAGATCATCTTCrCDAACC CC 
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B'U DCAGGTCTACTTTGGGATCATrGCCCTGTGAGGAGGACGAACATCCAACCTTCC CAAACC 
9Ui CCTCCCCTGCCCCAATCCCnTATTACCCCCTCCTrCAGACACCCTCAACCTCTTCTGGC 
961 TCAAAAACAGAATrCGCGGCTTAGGGTCGGAACCCAAGCTTAGAACTTTAAGCAACAAGA 
1021 CCACCACTTC GAAA CCTGG GATTCAGGAATGTGTGGCCTGCACAGTGAA DTGCTGGCAAC 
1081 CACTAAGAATTCAAACTGGGGCCTCCAGAACTCACTGGGGCCTACAGCTITGATCCCTGA 
1141 CATCT GGAAT CTGGACACCAGGGA GCCTTTGGTTCTGGC CAGAATGCTG CAGGA CTTGAG 
1201 AA5AC CTCACCTAGAAATrGACACAAGTGGACCTTAfiGCCrrCCTCTCTCCAGATGTTTC 
1261 CAGACTTCCTTGACACACGGAGCCCAGCCCTCCCCATGGAGCCACtCTCC CTCTATTTATG 
1321 TTTCCACTTGTGATTATrrATTArrTATTTAmTTTATTTATTTACAGATGAATGTATT 
138: TATTT GGDAGACCG GGGTATCCTG GGGGACCCAATGTAGGAGCTGC CTT DGCTC AGAC AT 
144: GTTTT C C GTGAAAA CGGAG CTGAACAATAGGCTGTTCCC ATGTAGC C C C CTGGC CTCT GT 
1501 GCCTrCTrrTGATTATGTTTnTAAAATATrrATCTGATTAAGTTGTCTAAACAATGCTG 
1361 ATTTC GTGAC CAACTGTCACTCATTGCreAGCCTCTGCTCCCCAGGDGA GTTGTGTCT GT 
1621 AATC G C C CTA CTATTCAGTGGCGAGAAATAAAGnTGCTTAGAAAAGAA*' 
I I ,JJJU -ri CI ass-2 El em ent (AR E 2) 
I I 3'UTR Tnfs^^i-ia mRHA 
CZU 5'UTR 7flr-3j;)A5mRMA 
Figure 5.1 Structure of TNF mRNA, and location of AU-rich elements (AREs). 
T h e full length nucleotide sequence of h u m a n Tnf c D N A ( E N S T 0 0 0 0 0 3 7 6 1 2 0 ) w a s 
taken from Ensembl . T h e sequence highlighted in yellow represents the A R E s ; green: 
5 ' U T R ; grey: 3 ' L J T R . 
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5.2 Roquin regulates TNF expression through its 3'UTR 
To test the hypothesis that Tnf 3 'UTR mRNA is required for Roquin's repression of 
TNF expression, I used the retroviral transduction assay described in the previous 
chapter, generating the construct Tn/^'^™. To do this, cDNA from the 3 'UTR fragment 
of Tnf niRNA, excluding the coding region, was subcloned into the multiple cloning site 
upstream of the IRES in the retroviral vector pR-IRES-huCD4 (Figure 5.2). 
A retroviral supernatant from this retroviral construct was harvested from Phoenix cell 
cultures and titrated as described in the previous chapter to achieve 50%-60% 
transduction. NIH3T3 cells were then co-transduced with retroviruses containing 
supernatants from: 
• Either pR-Roquin'^^-IRES-GFP or pR-Roquin'^''^''"-lRES-GFP or pR-
IRES-GFP empty vector 
plus 
• pR-7«/^'^™-IRES-huCD4 
Two days after transduction, NIH3T3 cells were analysed by How cytometry. The 
gating strategy used for this analysis is shown in Figure 5.3. GFP versus huCD4 
fluorescence was plotted to separately gate three different populations according to the 
level of GFP expression (GFP"', G F P ' a n d GFP^") for each of the three GFP vectors 
(Roquin^^, R o q u i n ' ^ o r empty vector). 
I quantified the level of TNF repression by the different Roquin vectors as the 
percentage of huCD4 level seen in cells transduced with the empty pR-IRES-GFP 
construct. 
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Figure 5.2 Schematic representations of the retroviral constructs. 
A. The 3'UTR of Tnf was inserted into the retroviral pR-lRES-huCD4 using the 
restriction enzymes Bglll and Xhol. 
pR-7n/^'"™-lRES-huCD4 
B. Wild-type (Roquin^^) and mutant (Roquin'^''^'^'^) Roquin cDNA were inserted 
into the retroviral vector pR-IRES-GFP using the restriction enzyme EcoR I. 
(ii) pR-Roquin^'^-IRES-GFP 
(iii)pR-Roquin^"''"-IRES-GFP 
(iv) pR-IRES-GFP (empty vector control) 
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Figure 5.3 
Flow cytometric analysis of NIH3T3 cells transduced with TNF 3'UTR and either 
Roquin^"^ (left) or Roquin^"'''^ (right). 
Dot-plots show GPP (Roquin) vs huCD4 (reporter of Tnf 3'LJTR) expression. The 
rectangular gates indicate GFP'"'' and GFP'^" populations (from top to bottom 
respectively) used to quantify Roquin's effect. 
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5.3 Roquin^'^^'^ causes an increase in Tnf 3'UTR-containing 
transcripts. 
Since huICOS is expressed from the bicistronic pR-IRES-huCD4 vector both 
TnfS'UTR and huCd4 are transcribed into a single transcript. Therefore, if the 
regulatory effect is a consequence of Roquin's regulation of TnfS'UTR mRNA 
abundance, a parallel shift in huCD4 expression should be observed in cells co-
transduced with vectors containing Tnf 3'UTR. 
HuCD4 expression was measured by flow cytometry. As observed in the case of Icos, 
Roquin^^ repressed huCD4 expression from transcripts containing Tnf 3'UTR. 
Nevertheless, this repressive effect was smaller (1.5-fold reduction of huCD4 
expression in GFP*" cells compared with OFP"^" cells, Figure 5.4A) than that observed 
for huIcos under the same experimental conditions (Figure 3.2: 8-fold reduction of 
ICOS expression and 4-fold reduction of huCD4 expression in GFP'^' cells compared to 
GFR"^"- cells). Strikingly, Roquin'^''^'''^ showed a potent enhancement of huCD4 
expression in GFP"' cells, to 130% of levels seen in GFP^" cells. Again, this effect 
contrasts with that seen for hiilcos, in which Roquin'^''^'^'^ also repressed expression, 
albeit less potently than Roquin^^. 
This experiment was carried out in triplicate and repeated twice (also in triplicate) to 
make sure the results were reproducible. In one of the two repeat experiments 
(experiment 2), there was no obvious repression exerted by Roquin"^^, highlighting the 
fact that the repression seen in A and C is subtle. Again, in both repeat experiments, 
transduction with Roquin'^'''^'^ constructs had a profound effect, increasing significantly 
the expression of huCD4 in GFP"' cells to 160% of the levels found in GFP^" cells 
(Figure 5.4 GFP"'). 
The results shown in both of these experiments differ from those obtained for Roquin's 
regulation of ICOS expression, in which both Roquin*^ and Roquin'^''^^'^ exerted a 
repressive effect on Icos 3 'UTR, although Roquin'^''^'^'^ was a less potent repressor. It 
thus appears Roquin'^'^'^'^ acts in a dominant negative fashion to increase (probably 
stabilize) Tnf 3'UTR mRNA. 
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Figure 5.4 Regulation of TNF expression by Roquin. 
N1H3T3 cells were transduced by two retroviruses: one expressing Tnf^ the other 
expressing either Roquin^^, R o q u i n " ^ o r an empty vector control. 
The regulation of TNF expression (as assessed by measuring MFI of the reporter 
huCD4) by Roquin^^ and Roquin'^'^'^'^ were compared using the same quantification 
method as described for the regulation of Icos in chapter 4. 
Open bars represent cells transduced with RoquinWT and filled bars represent cells 
transduced with RoquinM199R. Data shown represent mean values ±S.D with n=3. 
Student's test *P<0.05; **P<0.01. 
A, B and C show results for three separate experiments using the same vectors, but 
different batches of retroviruses. In experiments 1 and 3, but not in experiment 2, 
Roquin^^ appears to exert a mild suppressor effect. 
77 
Tentative explanations for the discordance between Roquin's regulatory effects on ICOS 
and TNF are provided in the discussion chapter. 
5.4 Roquin'^ '^ '^^  increases r«/3'UTR transcripts in a gene-dose 
dependent manner 
We also observed a gene-dose effect for Roquin's regulatory actions on Tnf 3 'UTR. 
Compared to the 160% levels of huCD4 expression in cells transduced with high levels 
of Roquin'^''''^'^ (GFP^') compared to GFP^" cells, cells transduced with low levels of 
Roquin^'*^^*^ (GFP'"^) had only a very modest increase in huCD4 (p<0.01). HuCD4 
levels in GFP''""' cells were only slightly higher (p<0.05) than those of cells not 
transduced with Roquin^''^'^'^ (Roquin^"). 
5.5 The 3'UTR of Tnf mRNA contains AREs and microRNA target 
sequences 
It is well known that the AU-rich elements (AREs) are important regulators of Tnf 
mRNA stability and control TNF-alpha biosynthesis (Hel et al, 1996; Jacob et ciL, 
1996). 
In the previous chapter I mentioned that ICOS regulation by Roquin appears not to 
depend on AREs, but on conserved miRNA target sites. In order to identify putative 
miRNA target sites within the 3 'UTR of Tnf mRNA, I used the software MiRanda for 
predicting miRNA target sequences. As illustrated in Figure 5.5. I found that the 3 'UTR 
of Tnf mRNA contains not only the well-known AREs (in yellow) but also several 
microRNA-target sites, including mmu-miR-149, mmu-miR-130a and mmu-miR-13()b 
(Figure5.5). These miRNAs have been reported to be expressed in myeloid cells 
(Monticelli et al., 2005). 
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Figure 5.6 
Predicted miRNA target sequences conserved between mice and human within the 
3 'UTR of Tnf mRNA, using the online bioinformatics software-MiRanda. 
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5.6 Summary 
In this chapter, 1 used retrovirus-mediated transduction of NIH3T3 cells to test whether 
the 3 'UTR Tnf mRNA can be regulated by Roquin and thus explain at the molecular 
level the increased levels of 7/?/mRNA found in activated sanwque macrophages. 
I have demonstrated that while Roquin^^ might exert a very mild repressive effect 
Roquin'^''^^'^ induces a striking increase in expression of mRNA expressed from a 
transcript containing Tnf 3'UTR mRNA. This suggests Roquin might act in a dominant 
negative fashion to regulate some of its targets. 
These results demonstrate TNF is also a target for Roquin's post-transcriptional 
regulation, and this regulation requires the 3 'UTR sequence. Since huCD4 is translated 
separately from the upstream transcript, the regulation observed is likely to occur at the 
level of mRNA abundance as opposed to regulation of translation. Further experiments 
blocking transcription with Actinomycin D and quantifying mRNA decay in double 
transduced cells are underway to confirm Roquin specifically regulates Tnf mRNA 
stability. 
Using bioinformatic tools we found that the 3 'UTR of Tnf mRNA contains several 
miRNA target binding sequences that are very conserved between human and mouse. 
We speculate Roquin might regulate Tnf mRNA stability acting through one or several 
of these miRNA-target sites. 
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General discussion 
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6.1 Limiting ICOS expression emerges as a novel mechanism to 
maintain immune tolerance 
A two-signal model of T cell activation has been used to explain how to prevent self-
reactive T cells that make it to the periphery from being activated, and thus maintaining 
T cell tolerance (Goodnow et ai, 2005; Lafferty et ai, 1980; Matzinger, 1994). 
According to this model, in addition to a signal through the T cell receptor (TCR) after 
binding its specific peptide forming a complex with MHC molecules, a second signal, 
named the co-stimulatory signal, is necessary for T cell activation and differentiation 
into an effector cell (Tafuri et ai, 2001). Co-stimulation mainly occurs through ligation 
of CD28 (Harding et ai, 1992). Although CD28 is constitutively expressed on T cells, 
its ligands B7.1 and B7.2 are generally only induced on antigen presenting cells (APCs), 
after exposure to foreign antigens (Carreno and Collins, 2002; Greenwald et ai, 2005; 
Nabavi et al., 1992). Therefore, self-reactive T cells are unlikely to receive the co-
stimulation from CD28 since APCs exposed to self-antigens do not upregulate B7 
molecules (Sharpe and Freeman, 2002) and M. Linterman (personal communication). 
It is paradoxical that while restricted co-stimulation through the CD28-B7s axis relies 
on the inducibility of B7 molecules on APCs. such restriction does not apply through 
the ICOS-ICOSL pathway. This is because, unlike CD28 ligands, ICOS ligand (ICOSL 
or B7h) is constitutively expressed on most APCs, including dendritic cells and B cells 
(Ling et ai, 2000; Yoshinaga et ai, 1999). In this situation, limiting the level of ICOS 
expression on naive T cells emerges as a crucial checkpoint to maintain T cell tolerance 
(Yu et ai, 2007). To my knowledge, no mechanisms besides the one proposed in this 
study have been described that operate to limit the expression of ICOS on T cells. 
There have been studies showing ICOS expression can be increased by transcriptional 
regulation, after combined stimulation through TCR and CD28 (Tan el al., 2006). It is 
assumed that, naive T cells have not received activation signals through 
TCR/CD28; it is only after these signals are received that T cells make the transition to 
become activated / effector CD44'"®'^  T cells. However, sanroque naive T cells already 
express significantly high levels of ICOS (Vinuesa et ai, 2005a), suggesting ICOS 
overexpression is not solely driven by transcriptional regulation. 
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My work and that of Di Yu has demonstrated that a novel mechanism regulating the 
degradation of basal level of ICOS transcripts is impaired in the presence of defective 
Roquin function. This results in aberrant overexpression of ICOS on naive T cells that 
might be sufficient to provide co-stimulation to self-reactive T cells that bind 
autoantigens, resulting in a break of T cell anergy and leading to autoimmune pathology. 
Since my experimental work concluded, Di Yu has demonstrated that halving the levels 
of ICOS on sanroque mice by generating Roquin ""^^""•Jcos'^^' mice (i.e. heterozygous 
for an Icos null allele) reduces the lymphadenppathy, splenomegaly, and T and B cell 
accumulation in the same proportion, although there is only a subtle reduction in TI H 
cell numbers, germinal centres and autoantibodies (Yu et ai, 2007). These mice still 
express twice the levels of Icos than Roquin^^ wild type mice. It will be important to 
see whether Icos deficiency in Roquin"'^^""\ico/' mice (currently being generated) can 
fully correct the lupus phenotype, or other Tin molecules that are also found 
overexpressed in sanroque mice such as IL-21 also contribute to the pathology. 
This theory of why ICOS overexpression on naive cells bypasses the requirement for 
CD28 co-stimulation and breaks tolerance could be formally tested by crossing 
sanroque mice to CD28 knockout mice. If this hypothesis is correct, a substantial 
amount of the sanroque pathology should still be obvious in mice lacking CD28. Indeed, 
these experiments are underway in my laboratory, and initial results suggest ICOS 
overexpression does overcome the need for CD28 co-stimulation during different 
phases of CD4^ immune responses (M. Linterman, personal communication). It will be 
interesting to see whether sanroque: CD28"'' mice still develop the lupus-like syndrome. 
Another explanation for the ICOS-driven break in tolerance may be its effects on TI.H 
cell homeostasis. ICOS signaling has been shown to be necessary for the development 
and maintenance of TI H cells and germinal centres (Akiba et al., 2005; Warnatz et al., 
2006). Thus, it is also possible that autoimmunity in sanroque mice is simply a 
consequence of enhancement of T^H generation and accumulation, due to Roquin*^ 
driven ICOS overexpression. There is substantial evidence to show TIH cells have the 
highest levels of ICOS expression (Hutloff et al., 1999), and these cells are very potent 
helpers of germinal centre B cells (Dong and Nurieva, 2003). The excessive number of 
TI H cells and spontaneous germinal center formation seen in sanroque mice support this 
possibility. 
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The two possibilities mentioned above are not mutually exclusive; in fact they are 
related to each other. For instance, both mechanisms contribute towards the generation 
of self-reactive THH cells, and thus both would help self-reactive germinal center B cells 
produce pathological high affinity autoantibodies. 
This novel checkpoint in T cell tolerance revealed by our research expands our 
understanding of the regulation of co-stimulation to maintain tolerance and suggests 
partial antagonism of ICOS signaling might prove a good therapeutic strategy for lupus 
patients with dysregulated TI H function. 
6.2 The role of Roquin in promoting Icos mRNA decay 
We have demonstrated Roquin represses ICOS expression through Icos 3'UTR mRNA 
(Figure 3.10). It is the most distal fragment, F3, within the 3 'UTR that plays an essential 
role in mediating this repression (Figure 4.1). Importantly, my experiments show that 
this repression reduces mRNA abundance (Figure 4.5). However, with this experiment 
alone we cannot unequivocally conclude that this effect is a consequence of accelerating 
Icos mRNA decay. In comparison with other fragments, for example Fl , only F3 was 
capable of mediating Roquin's repression on mRNA abundance. Since the cDNAs for 
Fl and F3 are separately subcloned into the multiple cloning site before the internal 
ribosomal entry site (lERS) it is possible that the F3 sequence, but not the Fl sequence, 
may affect the murine stem cell virus (MSCV) promoter and inhibit transcription of 
huCcl4 mRNA, thus reducing huCd4 mRNA levels measured by qRT-PCR. 
Nevertheless this would be extremely unlikely. Fortunately, our collaborator Andy Tan 
(from Kong Peng Lam's laboratory, Singapore) has performed the experiment that 
proves the increased levels of mRNA are a consequence of Roquin's effects on mRNA 
decay. He has been able to show that Roquin overexpression in EL4 cells (a T cell line) 
accelerates Icos mRNA decay, by measuring the half-life of endogeous Icos mRNA 
after inhibition of transcription with Actinomycin D (Yu et al, 2007). Our combined 
data show that Roquin limits Icos mRNA by enhancing mRNA decay through the F3 
segment within its' 3 'UTR. 
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6.3 The M199R mutation in Roquin impairs but does not abolish ICOS 
repression 
The experiments performed in this thesis show the M199R mutation in Roquin impairs 
its abiHty to repress ICOS expression (Figure 3.10). Nevertheless, the effects are mild. A 
priori, I would have expected to see a more dramatic effect, since it is this mutation that 
leads to the very dramatic overexpression of ICOS in sanroque mice. At least two 
different arguments may explain this discrepancy. First, in the original published 
experiments, it was clearly shown that overexpression of the M199R allele into 
sanroque T cells partially corrected the ICOS'"°^ phenotype, suggesting this allele had 
residual suppressive function, and could act in a manner comparable to Roquin, albeit 
with reduced efficiency when overexpressed. This is what is called a hypomorphic 
allele, as opposed to a loss of function allele. Second, the NIH3T3 cells used in these 
experiments have endogenous Roquin expression since Roquin is expressed 
ubiquitously. Thus, it is possible that wild type endogenous Roquin might still exert a 
suppressive effect on ICOS expression that cannot be fully inhibited by overexpression 
of mutant Roquin. Ideally, these experiments should be performed in Roquin knockout 
cells. 
The IVI199R mutation lies in the novel ROQ domain of the Roquin protein (Vinuesa et 
al, 2005a). The ROQ domain is essential to direct Roquin's localization to stress 
granules (V. Athanasopoulos. personal communication). Furthermore, a truncated form 
of Roquin lacking the ROQ domain completely loses the ability to repress ICOS 
expression (V. Athanasopoulos, personal communication). Together, these data suggest 
that localization of Roquin to SGs is crucial for Roquin's repression of ICOS expression. 
6.4 How does Roquin regulate mRNA decay? 
In SGs, translationally-arrested mRNAs are sorted so that they are routed either for 
degradation through the regulation of their stability or translation, or for re-initiation of 
translation (Anderson and Kedersha, 2006). Most proteins localizing to SGs such as 
eIF2/3/4E and HuR and TTP, have functions related to the regulation of translational 
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control and mRNA decay (Anderson and Kedersha, 2006). So the key question is how 
does Roquin act in SGs to promote Icos mRNA decay? There are several possibilities: 
Since Roquin has a CCCH zinc finger domain found in many RNA binding proteins, the 
simplest model would predict that Roquin specifically binds to Icos mRNA thereby 
recruiting it to SGs. This would prevent translation, which normally occurs in the 
cytoplasm. Once Roquin has bound Icos mRNA, it would enhance its decay, possibly 
recruiting the miRNA machinery. An important part of the puzzle we have not solved is 
determining whether Roquin can directly bind Icos mRNA (or any mRNA). To sort this 
out, we can use the supershift assay that is commonly used for analyzing specific 
protein-nuclear acid binding interactions. 
Another possibility is that the CCCH zinc finger domain simply aids Roquin to bind to 
RNA components in SO, and in doing so perhaps facilitate its recruitment to SGs, but 
does not specifically bind Icos mRNA. Once in SGs, Roquin may activate or enhance 
the machinery leading to Icos mRNA decay or direct Icos mRNA to P-bodies for further 
degradation. In order to prove this possibility, we would need some evidence to show 
that Roquin may bind non-specifically to different mRNAs and that Icos mRNA 
localizes to SGs independently of Roquin. The fact that Roquin also regulates tnf 
mRNA, supports the idea Roquin might regulate many different short-lived mRNAs. If 
this is true, it is highly unlikely Roquin can specifically bind to all its targets, and thus 
an indirect mechanism like the one proposed here would be favored. 
Another crucial question is whether the predicted E3 ubiquitin ligase activity of Roquin 
is required for ICOS repression. Roquin has a RINGl zinc-finger domain, which is 
found in many proteins with E3 ubiquitin ligase activity (Klug, 1999) and the Roquin 
homologue in C. elegcms, RLEl , has been shown to have ubiquitin ligase activity (Li et 
ai, 2007). Thus, we cannot exclude the possibility that Roquin regulates Icos mRNA by 
aiding ubiquitylation (and thus degradation) of proteins that would normally stabilize 
mRNA. In this way, Roquin deficiency would lead to accumulation of mRNA 
stabilizing proteins, and thus an increase in certain mRNAs, including that of Icos. 
Interestingly, the mRNA stabilizing protein HuR has been reported to function in a 
ubiquitin / proteasome-dependent manner and it also localizes to SGs (Gallouzi et ciL, 
2000; Kedersha and Anderson, 2002; Laroia et cil., 2002). Therefore, it is possible that 
Roquin mediates ubiquitylation followed by degradation of HuR and in doing so it 
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accelerates mRNA decay of HuR targets (which may include Icos mRNA). This could 
be tested by investigating the repression of ICOS by Roquin in the presence of a 
proteasome inhibitor. A different way to answer this question would be by investigating 
whether a mutant version of Roquin that has lost the E3 ligase activity can regulate 
ICOS expression. Replacing the first cysteine in the RING domain with an alanine has 
been shown to abolish Cbl 's E3 ligase activity; this same mutation could be introduced 
in Roquin to test this hypothesis. 
6.5 A potential role for miRNAs in the regulation of Icos mRNA 
There are several kinds of regulatory c/5-acting elements in mRNAs that can mediate 
mRNA decay. AU-rich elements (AREs) have been identified in a large number of 
mRNAs and have been shown to be potent regulators of mRNA stability (Khabar, 2005). 
However, there is no typical ARE motif ("AUUUA" sequence) within F3 of human Icos 
mRNA 3'UTR. Recently, miRNA target sequences within mRNAs are emerging as an 
important group of cw-acting elements regulating mRNA translation and decay (Barreau 
et ai, 2005; Jackson and Standart, 2007). Using in sitico analysis, Di Yu found several 
miRNA target sequences within the F3 region of Icos 3 'UTR, including a region 
complementary to miRNA-101 target sequence. This miRNA had been found to be 
expressed in T cells (Monticelli et ai, 2005). Introduction of a mutation in the Icos 
mRNA sequence complementary to the seed region (predicted to abolish miRNA 
binding) impaired Roquin's ability to repress ICOS expression, strongly suggesting 
miRNAs are important for Roquin's effects on ICOS expression (Yu et ai, 2007). 
6.6 TNF and other putative targets of Roquin's regulation 
The other important finding in this thesis is the identification of T/z/as another target for 
Roquin's regulation. My data shows TNF is also regulated by Roquin post-
transcriptionally. This is demonstrated by the experiment showing the 3'UTR of 
Tn/mRNA can mediate Roquin's regulation of the reporter huCD4. 
There are two striking differences between Roquin's effects on Icos and Tnf mRNA: 
1) While Roquin*^ exerts a potent suppressor effect on Icos mRNA. this is not so 
obvious in the case of 7>z/mRNA. In fact repression was only apparent in the first of 3 
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experiments performed (Figure 5.4). In experiment 2, there was no statistically 
significant repression of m/3 'UTR by Roquin. 
2) By contrast, while Roquin'^'^^'^ shows only a mild reduction in the repressive action 
of Roquin on Icos mRNA, it exerts a very potent effect upon Tnf mRNA, increasing the 
expression of the reporter huCD4 considerably (Figure 5.4). It appears as if Roquin"^ 
could be acting in a dominant negative way, i.e. the mutation in the overexpressed 
construct might be impairing the activity of endogenous wild type Roquin (which is 
maintaining the basal levels of TNF). 
A possible explanation for this is that Roquin may regulate Icos mRNA and T/z/mRNA 
through slightly different mechanisms. Tnf mRNA has been shown to be regulated by 
TTP, through binding of typical ARBs in its 3'UTR (Blackshear, 2002). Therefore, it 
would be important to establish whether Roquin's regulation of 7n/mRNA also occurs 
through AREs. If it is true that Icos mRNA is regulated by the miRNA machinery as 
speculated above, it is possible that the 1VI199R mutation in Roquin affects in different 
ways microRNA regulation vs classical ARE-mediated mRNA decay. 
The fact that Roquin regulates two different mRNAs post-transcriptionally, suggests 
that Roquin could have more targets. In the microarray experiments performed in our 
laboratory, most genes that showed increased mRNA levels in CD4"' T cells from 
sanroque mice (compared to wild-type littermates) are those genes classified as having 
short half-lives (Vinuesa et al., 2005a). It is then possible that all these short-lived 
mRNAs found in CD4^T cells (perhaps only during a particular maturation / activation / 
differentiation stage) are regulated by Roquin. 
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6.7 
poiyp^^^ 
Ribosome 
Fig. 6.7. Model of how Roquin regulates Icos expression 
In wild type T cells Icos transcription is induced by TCR and CD28 signaling; some 
Icos transcripts encounter Roquin in the cytoplasm or in SGs; Roquin then promotes the 
degradation of Icos transcripts; other Icos transcripts are translated to be expressed on 
the surface of T cells, where ICOS protein interacts with ICOSL to mediate 
costimulation signaling for T cell activation and differentiation. 
In sanroque T cells: the Roquin-mediated Icos mRNA decay is impaired by the 
mutation in Roquin so that there is much more ICOS expressed on the surface of T cells; 
unlimited ICOS expression breaks tolerance by activating self-reactive T cells, 
hyperactivating T cells or exaggerating aberrant differentiation. 
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